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ABSTRACT 
 
Melanocortin-5 Receptor Role in Energy Balance. (August 2011) 
Emily Nelson Jordan, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Caurnel Morgan 
 
Metabolic disorders, including obesity and fatty acid oxidation disorders (FODs), occur 
in approximately 34% of the American population and in 1 in every 10,000 Americans, 
respectively. Melanocortin-5 receptor (MC5R) is one of five G-protein coupled receptors 
that are known to mediate effects of melanocortins. Emerging evidence has linked 
MC5R to multiple metabolic disorders. Previous studies have provided evidence that 
MC5R helps to regulate lipid metabolism in the skeletal muscle, liver, and white adipose 
tissue, and in the skin and exocrine glands of vertebrates. We, therefore, tested the hypo-
thesis that MC5R promotes FAO in skeletal muscle. In the present study, MC5R knock-
out (KO) mice and wild-type (WT) mice were placed on a low-fat or high-fat diet for 9 
weeks. Methods including body weight gain and food intake determinations, behavioral 
testing to be assessed in future studies, insulin tolerance testing (ITT), and reverse tran-
scription PCR (RT-PCR) were used to provide a picture of overall energy balance and 
metabolic activity in tissues. Results suggest that obesity induced MC5R (KO) mice, rel-
ative to WT mice, display a decrease in FAO not only in the skeletal muscle, but in the 
liver as well. We also show that to compensate for the loss of FAO in skeletal muscle, 
MC5R KO mice experience an increase in FAO in brown adipose tissue (BAT) and an 
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increase in adipogenesis in the liver. Not only does lipid metabolism activity shift to liv-
er, data suggests that the glycolytic activity in skeletal muscle decreases and is again 
reallocated to the liver. Furthermore, we demonstrate that insulin sensitivity is main-
tained in MC5R KO mice on high-fat diet, in contrast to the decrease in sensitivity in 
WT mice on high-fat diet.  These data collectively suggest that MC5R is extensively in-
volved in overall lipid and glucose metabolism and not only shifts lipolysis and lipoge-
nesis in the body, but may be involved in the dissociation of obesity and insulin resis-
tance.  
. 
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CHAPTER I 
INTRODUCTION 
The project goal was to determine the role of MC5R in lipid metabolism. The central 
hypothesis that was tested in this project, is that MC5R activation stimulates lipid meta-
bolism in skeletal muscle, was derived from preliminary data in the Morgan laboratory 
and the work of An and coworkers (2007) (1). The general approach that was used to 
test this hypothesis was to assess changes in biomarkers of metabolism using MC5R 
wild-type and knockout mice. This work is significant because it will advance the under-
standing of the role of MC5R in lipid metabolism and metabolic disorders. The approach 
was innovative because it used a unique MC5R mouse model on high-fat diet in order to 
make these advances. The predicted outcome was that the genetic deletion of MC5R 
globally will reduce fatty acid oxidation in skeletal muscle and, consequently, shift the 
burden of FAO to other tissues that do not express high levels of MC5R (e.g., liver). 
This outcome will have a positive impact because it helps to identify MC5R as a thera-
peutic target in metabolic disorders. 
 
 
 
 
 
 
____________ 
This thesis follows the style of American Journal of Physiology-Endocrinology and Me-
tabolism.  
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CHAPTER II 
 
LITERATURE REVIEW 
RESEARCH JUSTIFICATION 
  
Impact of Metabolic Disorders 
 
According to the Morbidity and Mortality Weekly Report, 26.7% of adults in the United 
States are self-reportedly obese in 2009, and 33.8% in 2008, when surveyed by 
NHANES (19). Within the last 8 to 9 years, obesity among men and women, ages 40-59, 
increased approximately 35% (19). The obesity epidemic in the United States is begin-
ning to affect both adults and children. Studies have shown a higher prevalence of obesi-
ty among adults who were obese as children or adolescents. Diet, parental obesity, and 
obesity-related gene polymorphisms contribute to the development of obesity (2). The 
repercussions of obesity does not simply affect quality of life, an issue of morbidity can 
be presented. Long-term obesity is often associated with the development of metabolic 
syndrome. One review defines metabolic syndrome as the presence of at least three of 
the following criteria: elevated triglycerides, low levels of high-density lipoproteins 
(HDL), abdominal circumference above the 90th percentile by sex, elevated fasting glu-
cose, and high blood pressure (2). Additionally, obesity is frequently associated with the 
development of type-2 diabetes and the increased risk and worsened prognosis of many 
types of cancer (2, 28). With all factors combined, the risk of mortality and morbidity is 
higher with obesity.   
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Obesity and Diabetes 
 
As mentioned above, there is significant association between obesity and the onset of 
type-2 diabetes (2, 7). The cycle can begin two ways: an increase in fat mass or the de-
velopment of insulin resistance. First, the development of adiposity during the develop-
ment of obesity can be the cause of systemic insulin resistance. The adipose tissue is en-
larged and the tissue develops a low grade chronic inflammation (27). The inflammation 
allows macrophage infiltration and production of pro-inflammatory cytokines. The cyto-
kine production, along with macrophage presence, causes adipose tissue dysfunction, 
increasing pro-hyperglycemic factor production and decreasing anti-hyperglycemic fac-
tor production (27). When combined, these aspects lead to systemic insulin resistance. 
Second, the cycle can begin by glucose uptake activated by insulin in the cell, the stimu-
lation of lipogenesis, and the inhibition of lipolysis (57). An elevated fasting glucose 
level causes a cell to become insulin resistant, which disrupts glucose and lipid homeos-
tasis pathways and produces elevations in fasting and postprandial glucose and lipid le-
vels (57). The increase in lipid levels increases adiposity and eventually obesity. The re-
lationship between obesity and insulin resistance has become a major issue in today’s 
society. As obesity increases, so does the higher percentage of people who have type-2 
diabetes. A further understanding of the mechanisms responsible for this association 
would be valuable, benefitting both the health status financial burden of the obese with 
type-2 diabetes. 
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Fatty Oxidation Disorders 
 
Another set of metabolic disorders involve the disruption of lipid metabolism, as with 
medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. These so-called FODs are 
common and inherited disorders that disrupt FAO. FODs stimulate hepatic ketogenesis, 
which becomes a major energy source when glucose is less available (41, 59). If FAO is 
insufficient, people diagnosed with FODs are unable to oxidize fatty acids for fuel, creat-
ing an energy shortage. Since MCAD deficiency is a genetic disorder, patients from 
childhood experience hypoketotic hypoglycemia, vomiting, and lethargy, and common 
infections (41). Liver disease and seizures may also develop. Eventually, the resultant 
metabolic stress can induce a coma and ultimately, death. The disease is usually detected 
between 3 months and 2 years of age. If MCAD deficiency is correctly diagnosed, the 
child can survive into adulthood by avoiding high fat foods and any prolonged period of 
fasting. If MCAD deficiency is not properly identified, at least 18% of affected individu-
als die during their first metabolic crisis (41). Increasing the understanding of FAO 
would expand the knowledge base from which effective treatment of FODs is expected 
to arise.   
 
Melanocortins 
 
The principal melanocortins include alpha-, beta-, and gamma-melanocortin stimulating 
hormones (α-MSH, β-MSH, and γ-MSH), as well as adrenocorticotropic hormone 
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(ACTH) (15). These melanocortin peptides are post translational products that are de-
rived enzymatically from the pro-opiomelanocortin (POMC) precursor protein (15, 21).  
In the hypothalamic brain region, POMC neurons are sites of convergence of a variety of 
peripheral and central hormones, neurotransmitters, and nutrients involved in the regula-
tion of feeding behavior (20, 45). Melanocortins, particularly α-MSH and ACTH, are 
also known to regulate metabolic functions in peripheral tissues (e.g., adipose) (1, 15). 
 
Melanocortin Receptors 
 
Five melanocortin receptor (MCR) sub-types are known to mediate biological actions of 
melanocortins (9). Melanocortin-1 receptor (MC1R) is expressed in epidermal and folli-
cular melanocytes, and it stimulates melanogenesis (22, 39). MC2R, in the adrenal cor-
tex, mediates the effects of ACTH on corticosteroid secretion (13, 51). MC3R,MC4R, 
and MC5R all are found in the brain (20, 37, 56). Central MC3R and MC4R are impor-
tant for body weight regulation (5, 8, 16, 24). Functions for MC5R in the central nervous 
system have not been investigated extensively, but there is evidence that it may be in-
volved in the control of pituitary hormone secretion (46).  
 
 
 
Peripherally, MC5R mRNA and protein are expressed abundantly in exocrine glands, 
including sebaceous, lachrymal, and preputial glands (8, 66). Chen and co-workers 
(1997), using mice that were genetically engineered to be MC5R-deficient, found that 
MC5R deficiency caused defective lipid metabolism in sebaceous glands (8). Morgan 
and co-workers (2004) found that MC5R deficiency reduced the content of specific li-
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pid-based pheromones in the preputial glands of male mice (45). Although MC5R 
mRNA has been reported to be expressed in adipose, skin, muscle, liver, adrenal gland, 
and testis, in some tissues, the reports have been conflicting, and most have not been 
confirmed at the protein level (1, 9, 17, 35, 55). MC5R’s metabolic activity has not been 
widely studied, but investigated primarily in relation to the skin, skeletal muscle, liver, 
and white and BAT (1, 8). As indicated in Figure 1, we confirmed by RT-PCR that 
MC5R is expressed in mRNA of BAT, skeletal muscle, testes, spleen, heart, omental fat, 
and may be marginally expressed in kidney and liver. In liver, we do not see the ex-
pected MC5R amplicon; instead we see genomic DNA amplification at approximately 
900 base pairs. Genomic DNA can bind to primers, is intron spanning, and if amplified, 
results in an amplicon with a large molecular weight. When amplifying MC5R in the 
spleen, we see a non-specific amplicon at approximately 250 base pairs. This is most 
likely an alternate MC5R priming site binding the primers used.  
 
 
 
 
 
 
 
 
 
7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MC5R and Adipose Function 
 
White adipose tissue (WAT) BAT and have been reported to express MC5R, and emerg-
ing evidence suggests that this MCR subtype might be upregulated during adipocyte dif-
ferentiation or adipogenesis (29).  Furthermore, the administration of α-MSH has been 
shown to alter lipid metabolism in adipose tissue by inhibiting adipogenesis, stimulating 
lipolysis, and inhibiting the expression and secretion of the adipocyte hormone, leptin, in 
the 3T3-L1 mouse adipocyte cell line (29).  
 
In addition to this evidence suggesting direct regulation of lipid metabolism in adipo-
cytes, melanocortins have been shown to alter the expression of genes that regulate lipid 
MC5R 
ActB 
1 2 3 4 5 6 7 8 M 
Figure 1. MC5R Tissue Distribution. Tissues obtained from 
wild-type mice, 18 weeks of age on LFD feeding, were used to 
analyze the presence of MC5R by RT-PCR: (1) BAT, (2) Liver, 
(3) Skeletal Muscle, (4) Testes, (5) Spleen, (6) Heart, (7) Omental 
Fat, (8) Kidney. Beta-actin (ActB) was used as the standard. 
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metabolism. For example, one study investigated the relationship between the adipocyte 
cytokine, interleukin-6 (IL-6), and the melanocortin system (33). In addition to its role in 
the immune response, IL-6 influences lipid metabolism and insulin sensitivity (33). 
When 3T3-L1 adipocytes were incubated with α-MSH, IL-6 production increased. 
MC5R and MC2R are thought to be the most abundant MCR sub-types expressed in 
adipose, and α-MSH has low affinity for MC2R. Therefore, MC5R likely accounts for 
the IL-6 increase, and subsequent metabolic actions of IL-6 (33).  
 
MC5R and Liver Function 
 
MC5R function in the sea bass was found to stimulate hepatocyte lipolysis in this spe-
cies (58). While all five melanocortin receptors are present in the tetrapod species, only 
3 MCR’s have been considered for function.  MC1R has been studied in relation to the 
color patterns of fish, MC2R has been associated with cortisol secretion regulation in the 
fish, and MC4R has been linked to food intake and energy balance in the fish. MC3R 
and MC5R have not been characterized in relation to function in fish. This group found 
sea bass MC5R expressed in various isoforms, and that the administration of melanotan-
II (MT-II), an agonist for MC5R, MC4R, and MC3R, increased the FAO in the liver. 
When sea bass liver cells were treated with MT-II, levels of non-esterified fatty acid 
(NEFA) increased within 4 hours. The increase in NEFA provides evidence of direct 
regulation of hepatic lipid metabolism by MC5R activation (58). Whether MC5R plays a 
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similar role in the livers of other vertebrates, including mammals, remains to be deter-
mined.  
 
MC5R and Skeletal Muscle Function 
 
MC5R is abundantly expressed in skeletal muscle, and its effect on lipid metabolism was 
examined in vivo and in vitro, using the C2C12 mouse skeletal muscle cell line (1, 8). 
First, mice injected with α-MSH, exhibited elevated activity of carnitine palmitoyltrans-
ferase-I (CPT-I), a rate limiting enzyme in FAO. Second, incubation of C2C12 cells with 
α-MSH increased the oxidation of the fatty acid, palmitate. To determine which MCR 
sub-type was responsible for this increase in FAO, different MCR modulators were ad-
ministered. SHU9119 acts as an MC5R agonist and as an antagonist of MC3R and 
MC4R.  Administration of SHU9119 increased palmitate oxidation in the cell line, sug-
gesting modulation MC5R responsibility FAO. These results provide evidence that acti-
vation of MC5R in skeletal muscle increases FAO in the mouse and C2C12 skeletal 
muscle cells. These findings suggest that additional in vivo studies might provide addi-
tional physiological evidence of an association between MC5R and lipid metabolism. 
 
MC5R in Skin Function 
 
MC5R mRNA and protein have been reported in sebaceous glands of the skin (74). 
MC5R regulates lipid synthesis, storage, and secretion in sebaceous glands, as well as 
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other exocrine glands. MC5R’s role in the mouse preputial gland, which is a modified 
and macroscopic sebaceous gland, was studied in relation to lipid metabolism (45). Ear-
lier studies had shown that melanocortins increased preputial gland lipogenesis and the 
synthesis and release of lipid-based pheromones (9, 10). Melanocortin administration to 
mice stimulated the preputial biosynthesis and secretion of lipid-based pheromones that 
influenced aggressive behaviors in male wild-type mice, but not in MC5R null mutant 
mice (10). Moreover, MC5R deficiency reduced specific lipid-based compounds in the 
mouse preputial gland (44).  
 
MC5R and Metabolic Disorders 
  
Obesity and insulin resistance are important metabolic disorders that have been linked to 
MC5R expression. The Quebec Family Study investigated the relationship between me-
tabolic defects and MC4R or MC5R (6). The subjects, French-Canadians from the great-
er Quebec City region, were divided into groups by weight, and various metabolic and 
genetic parameters were analyzed. A strong association between MC5R and obesity 
phenotypes was suggested. Among males, there appeared to be significant linkages be-
tween MC5R and body mass index, fat mass, and resting metabolic rate. Women only 
experienced a linkage between MC5R and body mass index (6).  
 
Another study assessed in morbidly obese and lean Finnish subjects, relationships be-
tween polymorphisms in the genes for ectonucleotide pyrophosphatase phosphodieste-
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rase-1 (ENPP1) and MCR sub-types, and obesity and insulin sensitivity. ENPP1, is an 
enzyme that has been implicated in obesity, insulin resistance, and type-2 diabetes (64). 
Twenty-five single-nucleotide polymorphisms (SNPs) for ENPP1 and each MCR sub-
type were used as genetic markers. There was an association between SNPs in the 
MC5R and ENPP1 genes with obesity and insulin resistance, or type-2 diabetes (64). 
These findings suggest that MC5R might play a role in the development of metabolic 
disorders that affect the 36.6% and 26.5% percent of Americans who are overweight and 
obese, respectively (25).  
 
SUMMARY 
 
Defective lipid metabolism is crucial for the development of several metabolic disorders 
and, emerging evidence outline above suggests that melanocortins act through MC5R to 
regulate lipid metabolism. Most of this evidence, however, was generated using mam-
malian cells in vitro, and some of it was generated in fish. Our preliminary experiments 
suggested that MC5R might play a crucial role in the lipid metabolism in vivo, using the 
C57BL/6 strain of mouse, which is susceptible to the development of obesity during 
high-fat feeding. In addition, this obese mouse model can develop metabolic syndrome-
like state, which can include obesity, insulin resistance, inflammation, cardiovascular 
disease, etc. We, therefore, sought to investigate the interactions between MC5R and 
high-fat feeding in MC5R wild-type and knockout mice on the C57BL/6 genetic back-
ground.  
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CHAPTER III 
 
MELANOCORTIN-5 RECEPTOR ROLE IN ENERGY BALANCE 
INTRODUCTION 
 
Determining the mechanism by which MC5R stimulates lipid metabolism is a significant 
step in understanding metabolic disorders that involve the melanocortin system. Defec-
tive lipid metabolism is crucial for the development of these disorders, including me-
dium-chain acyl-CoA dehydrogenase (MCAD) deficiency, obesity, and diabetes, and 
emerging evidence suggests that melanocortins act through MC5R to regulate lipid me-
tabolism. The effects of these disorders, or the disorder as a whole, could be alleviated if 
the role of MC5R in metabolism could be better understood. It has been suggested that 
central MC3R and MC4R are important for body weight regulation (5, 8, 16, 24). MC5R 
might be similarly involved in regulating genes responsible for lipid metabolism in dif-
ferent tissues. The findings that MC5R is involved in FAO in skeletal muscle by utiliz-
ing C2C12 mouse muscle cells suggests that supplementary in vivo studies might present 
additional physiological evidence of an association between MC5R and lipid metabolism 
(1, 3). The outcome of this project will have a positive impact because it is likely to 
identify MC5R as a therapeutic target for metabolic disorders. We, therefore, sought to 
investigate the interactions between MC5R and high-fat feeding in WT and MC5R KO 
mice.  
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MATERIALS AND METHODS 
 
Animals and Diets 
 
Virus free male mice of the C57BL/6J strain were obtained from Harlan (Indianapolis, 
IN) at 8 weeks of age. Male Melanocortin-5 Receptor (MC5R) knockout mice, which 
were originally generated and backcrossed for more than 12 generations at OHSU, were 
bred in the Kleberg laboratory animal facilities at Texas A&M University (43). At time 
of arrival, the mice were housed in individual cages in a temperature-controlled room 
with a 12-hour light/dark cycle. After 1 week of adaptation, the mice were randomly se-
parated and allowed access to water and either a low-fat diet (LFD) or high-fat diet 
(HFD) ad libitum for 9 weeks. The low-fat diet, LFD, was composed of: 14% of calories 
in the form of fat, 33% in the form of protein, and 53% in the form of carbohydrates. 
The kilocalories contributed by fat were primarily contributed by soy bean oil. The high-
fat diet, HFD, was composed of: 45% of calories in the form of fat, 20% in the form of 
protein, and 35% in the form of carbohydrates. The carbohydrates present were corn 
starch (21%), maltodextrin (29%) and sucrose (50%). The proportions of the various 
fats, making up 45% of kilocalorie content were soybean oil (12%) and lard (88%). Di-
ets were obtained in pellet form from Research Diets (New Brunswick, NJ).  
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Procedure 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Timeline of Experiment 
 
Timeline. An illustration of the study’s timeline is shown in Figure 2.  The duration of 
this particular study was 18 weeks. The Harlan WT mice arrived at 8 weeks of age and 
were allowed to acclimate for 1 week. The MC5R KO mice were age matched appro-
priately with the Harlan mice. At 9 weeks of age, all mice were placed on their respec-
tive diets for 9 weeks. Behavioral Testing, which will be analyzed in a future study, was 
performed on all mice at 16 weeks. Insulin Tolerance Testing (ITT) was performed on 
each animal at 17 weeks of age. The mice were given 1 week to recover, then were hu-
manly sacrificed by euthanasia followed by decapitation.  Multiple tissues were ex-
 ITT 
Behavioral 
Testing Euthanasia 
  Low-fat diet 
  High-fat diet 
Adaptation 
week 
Age 
(weeks) 
     8            9                16             17           18  
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tracted; tissues analyzed include liver, skeletal muscle, omental (white) adipose, and 
brown adipose. 
 
Assays 
 
Body Weight Gain and Food Consumption Determination. Body weight gain and food 
intake were determined for each animal twice a week for the duration of the study.  Body 
weight gain was determined by taking the final weight (to the nearest 0.1g) and subtract-
ing the initial weight. Food consumption was determined by subtracting the weight of 
food left on the grid and the weight of spilled food from the initial weight of food sup-
plied (to the nearest 0.1g).  Water consumption was not recorded. 
 
Behavior Testing. Mice were tested for behavioral differences at 16 weeks of age. Tail 
suspension was used to determine depressive-like behavior in the mice. To perform the 
test, the mice were suspended by their tails for 10 minutes and were recorded. The beha-
vior analysis data will be used in a future study.  
 
Insulin Tolerance Test (ITT) Analysis. Mice were fed their respective diet ad libitum 
during the testing. They were injected (i.p.) with 0.75m U/g body wt human insulin (Lil-
ly, Indianapolis, Indiana). Blood samples were drawn from the tail vein at different time 
points: before insulin injection (0 min), 15 min, 30 min, 45 min, and 60 min after injec-
tion. Plasma was extracted and combined with a glucose reagent. Glucose concentrations 
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were quantified by measuring the absorbency of the plasma-glucose solution. Values 
were then calculated as a percentage of the initial time point (0 min) value.    
 
Tissue Sample Collection. Following anesthetization and termination by cervical dislo-
cation, the following tissues were removed: liver, pancreas, brain, ears, preputial glands, 
kidneys, heart, skeletal muscle, inguinal adipose tissue, perigonadal adipose tissue, re-
troperitoneal adipose tissue, omental adipose tissue, BAT, spleen, testes, stomach, which 
was cut open and washed in PBS to remove food particles, and colon, which was rinsed 
through with PBS to remove digestive remnants. All tissues were immediately weighed, 
placed into liquid nitrogen, and stored at -80 degrees Celsius in foil packets. 
 
RT-PCR. RNA was extracted (see Appendix B) from liver, skeletal muscle, omental 
(white) adipose, and BAT. RT-PCR was performed on these samples. Qualitative PCRs 
for various genes was carried out in a Mastercycler Thermal Cycler (Eppendorf AG, 
Hamburg, Germany). Two microlitres of the RT reaction was amplified in a total volume 
of 20 ml containing 50% REDTaq Ready Mix Reaction Buffer (Sigma Aldrich; St. 
Louis), two complimentary primers at a concentration of 10 nmol each and sterile water. 
The primer sequences were created and ordered from Integrated DNA Technologies 
(Coraville, Iowa). The PCR for all targets consisted of similar temperatures and time 
lengths, with varying number of cycles for amplification. PCR that was performed con-
sists of initial denaturation at 95 C for 50 s, and a cycle of: denaturation at 94 C for 20s, 
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annealing at 60 C for 20s, and elongation at 72 C for 30-60s. Table 1 shows a list of pri-
mers used in RT-PCR for each tissue analyzed. 
 
 
 
 
 
 
 
 
 
 
 
Statistical Analyses. WT and KO mice were fed either a LFD or a HFD. This resulted in 
the following treatment combinations: WT-LF (n = 5), KO-LF (n = 4), WT-HF (n = 5), 
and KO-HF (n = 4). Two-way analysis of variance (ANOVA) was used to determine the 
effects of HFD treatment. The body weight gain and food intake measurements and the 
ITT analysis represent a split-plot design. For post-test analysis, the Bonferroni t-test 
was used for multiple comparisons of means. Post hoc data were analyzed with Graph 
Pad Prism 4.0 (San Diego, CA) and SigmaStat 2.0 statistical software (SPSS; Chicago, 
IL).  Differences with p-values less than 0.05 were deemed statistically significant. Re-
sults are presented as mean ± SEM.   
Table 1. List of Primers Used in RT-PCR on Various Tissues 
Tissue Skeletal Muscle Liver Omental Fat Brown Fat 
Primers MCAD 
LCAD 
PPARα 
AKT1 
PFK-1 
AMPKa 
 
MCAD 
LCAD 
PPARα 
AKT1 
PFK-1 
FGF-21 
HSL 
DGAT2 
MCAD 
LCAD 
PPARγ 
AKT1 
SREBP1c 
MCAD 
LCAD 
PPARγ 
AKT1 
SREBP1c 
FGF-21 
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RESULTS 
 
Tissue Weights 
 
MC5R plays a role in metabolism, and as a result, tissue weights of WT and MC5R KO 
mice are variable (Table 2). 
 
 
Table 2. Animal Tissue Weights (mg) 
Tissues WT-LF KO-LF WT-HF KO-HF 
Liver (abs) 1479 ± 258 1118 ± 36* 1633 ± 246 1275 ± 31*†† 
Liver (norm) 48 ± 2.3 45 ± 1.4 42 ± 3.1 36 ± 1.4†† 
Pancreas (abs) 157 ± 22 149 ± 15 193 ± 38†† 218 ± 31*†† 
Pancreas (norm) 5.1 ± 0.2 6 ± 0.6 5 ± 0.5 6.1 ± 0.9 
BAT (abs) 154 ± 55 113 ± 21 360 ± 122†† 252 ± 60† 
BAT (norm) 4.9 ± 0.6 4.5 ± 0.8 9.2 ± 1.3†† 6.9 ± 1.4 
Preputial Glands (abs) 108 ± 21 87 ± 25 129 ± 11 89 ± 10** 
Preputial Glands (norm) 3.5 ± 0.3 3.5± 0.5 3.3 ± 0.1 2.5 ± 0.3* 
Kidney (abs) 410 ± 49 323 ± 9* 428 ± 25 418 ± 24† 
Kidney (norm) 13.4 ± 0.4 12.9 ± 0.3 11 ± 0.4†† 11.8 ± 0.7 
Skeletal Muscle (abs) 1071 ± 459 1055 ± 20 1302 ± 85 1346 ± 9† 
Skeletal Muscle (norm) 36.5 ± 8 42.1 ± 1 33.6 ± 1.4 38.1 ± 3.3 
Inguinal Fat (abs) 420 ± 362 289 ± 71 1530 ± 663† 1226 ± 395† 
Inguinal  Fat (norm) 13 ± 4.6 11.5 ± 2.8 39 ± 7.8† 33.1 ± 8.8 
Perigonadal  Fat (abs) 630 ± 239 395 ± 38 2217 ± 422†† 1945 ± 199†† 
Perigonadal  Fat (norm) 20.1 ± 2.6 15.8 ± 1.5 56.9 ± 5†† 54.3 ± 2.5†† 
Retroperitoneal  Fat (abs) 230 ± 163 127 ± 48 828 ± 226†† 741 ± 161†† 
Retroperitoneal  Fat (norm) 7.1 ± 2 5.1 ± 2 21.2 ± 2.6†† 23.6 ± 2.9†† 
Omental  Fat (abs) 201 ± 198 114 ± 23 919 ± 242†† 521 ± 141*† 
Omental  Fat (norm) 6.1 ± 2.6 4.5 ± 0.9 23.6 ± 2.9†† 14.2 ± 3† 
Genotype : * P < 0.05; ** P < 0.01   Diet : † P < 0.05; †† P < 0.01   
Abs = mg tissue, Norm = mg tissue/kg body weight 
Means ± SEM are shown 
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Post hoc analysis using Bonferroni’s t-test indicated many significant differences in tis-
sue weights; absolute and normalized to body weight (mg/kg).For example, the size of 
the livers varied with genotype and diet. On both diet groups, the average weight of the 
KO liver was statistically significantly less than the WT liver. Interestingly, the KO liver 
did increase in size when the animal was placed on high-fat diet, but the WT liver did 
not. In skeletal muscle, there was no genotypic effect, but there was a significant dietary 
effect in the KO mice. On high-fat diet, KO skeletal muscle was larger than low-fat diet, 
while WT skeletal muscle was not altered by high-fat diet. Lastly, all of the adipose tis-
sue regions displayed statistically significant genotypic and dietary differences. While 
both genotypes on high-fat diet showed an increase in adipose tissue weight, the majori-
ty of WT high-fat diet adipose tissue areas had more statistical differences than KO 
high-fat, when compared to their low-fat diet counterparts. The perigonadal adipose re-
gion was the only fat region in which KO and WT mice exhibited similar statistical dif-
ferences. These data suggest that not only didMC5R depletion in mice cause the liver to 
reduce in size; the deletion caused the liver and skeletal muscle size to be affected by 
diet. Only KO liver and skeletal muscle increased in weight when given high-fat diet, 
suggesting the two tissues were not burning fat but storing it. Furthermore, by measuring 
various adipose regions, it can be suggested that the mice on high-fat diet did become 
obese and that MC5R may play a role in the rate at which an animal deposits fatty acids  
in different adipose regions.
 20 
Body Weight and Food Intake Analysis 
 
Body Weight Analysis. In relation to tissue weights, analysis of the final body weight 
gain and the body weight gain patterns of the four treatment groups showed significance 
differences. The average body weight gain from week to week is shown in Figure 3. 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 3. Body Weight. Findings: There was a genotypic effect, a dietary effect, and effect of 
time, a genotype by diet interaction, and a diet by time interaction. Methods: WT and MC5R KO 
animals (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal from fat) for 9 weeks. 
Body weight was measured twice a week.  Statistics: Means are shown (± SEM). 
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Various significant genotypic and dietary differences in body weight between the 4 
treatment groups were evident. Three-way ANOVA indicated a genotypic effect (F = 
71.174 ; p < 0.001), a dietary effect (F = 350.907 ; p < 0.001), an effect of time (F = 
9.256 ; p < 0.001), a genotype by diet interaction (F = 23.458 ; p < 0.001), and a diet by 
time interaction (F = 2.393 ; p = 0.015), but no genotype by time interaction (F = 0.469 ; 
p = 0.894), or an interaction of the three factors (F = 0.104 ; p = 1.0).  Although KO 
mice had an initial weight 4 grams less than WT, when fed the low-fat diet both WT and 
KO mice gained less than 2.5 grams, from initial weight, throughout the duration of the 
experiment. In contrast, WT mice on high-fat diet gained approximately 12 grams and 
KO mice on high-fat diet gained approximately 8.5 grams throughout the 9 weeks. On 
low-fat diet, both genotypes have similar weight gain, but when fed high-fat diet, WT 
mice exhibit a higher rate of weight gain than KO mice in the 9 week experiment. This 
suggests that the MC5R may assist in regulating metabolism when an animal if given 
excessive dietary fat.  
 
In addition, there were various significant differences in body weight gain, as seen in 
(Figure 4) between the 4 treatment groups throughout the 9 week experiment. 
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Figure 4. Body Weight Gain. Findings: There was a dietary effect, an effect of time, and a diet by time 
interaction. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or 
HFD (45% kcal from fat) for 9 weeks. Body weight was measured twice a week.  Statistics: Means are 
shown (± SEM). 
 
Significant differences between treatment groups were seen in 8 of the 10 weeks (Table 
3). 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Body Weight Gain (mg) 
Age WT/LF KO/LF WT/HF KO/HF 
(weeks)     
9 300 ± 490 350 ± 160 2300 ± 730†† 2750 ± 810†† 
10 1060 ± 450 470 ± 140 2100 ± 810† 1320 ± 580† 
11 700 ± 220 600 ± 170 3260 ± 1210† 1470 ± 760 
13 480 ± 870 -600 ± 170 140 ± 1130 250 ± 590† 
15 1120 ± 1000 -250 ± 610 1440 ± 750 1620 ± 1470 
16 -60 ± 500 -200 ± 510 660 ± 980 1350 ± 560†† 
17 620 ± 810 870 ± 670 -20 ± 810 -1100 ± 1170† 
18 -460 ± 430 -370 ± 550 1140 ± 1050 1450 ± 890 
     
Total 3960 ± 1080 1500 ± 430* 11000 ± 3300†† 9050 ± 1200†† 
Diet : † P < 0.05; †† P < 0.01   
Means ± SEM are shown 
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Three-way ANOVA indicated a dietary effect (F = 45.947 ; p < 0.001), an effect of time 
(F = 8.485 ; p < 0.001), no genotypic effect (F = 2.408 ; p = 0.123), a diet by time inte-
raction (F = 6.596 ; p < 0.001), but no genotype by diet interaction (F = 0.290 ; p = 
0.591), genotype by time interaction (F = 1.472 ; p = 0.164), or an interaction of the 
three factors (F = 1.673 ; p = 0.101). All differences in body weight gain were seen be-
tween low-fat diet and high-fat diet groups of the same genotype. The majority of these 
differences are between the KO genotypes. The data suggests that MC5R may have an 
effect on body weight gain over time and again, on overall metabolic regulation. Addi-
tionally, the decline in weight gain seen from week 16 to 18 could be attributed to testing 
done on the mice. Week 16’s behavioral testing and week 17’s ITT may have negatively 
affected weight gain for both genotypes, with KO weight gain decreasing more severely 
than WT weight gain. The excess insulin in the mice’s system may have harmfully af-
fected KO food intake further than the WT food intake. This suggests that different sti-
muli affects KO mice, in both diet groups, more largely than WT mice. 
 
Total body weight gain (Figure 5) not only varied as suspected between diets, WT and 
KO mice gained significantly different amounts of weight on low-fat diet. 
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Figure 5. Total Body Weight Gain. Findings: There was a dietary effect. Methods: WT and MC5R KO 
mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Body 
weight was measured twice a week.  Statistics: Means are shown (± SEM). For genotype: *p < 0.05.  For 
diet: † p < 0.05; ††p < 0.01. 
 
For overall weight gain, two-way ANOVA indicated a dietary effect (F1,14= 42.769; p < 
0.001), no effect on genotype x diet interaction (F1,14 = 0.0523; p = 0.822), and a trend 
for a genotypic effect (F1,14 = 3.907; p = 0.068). First, on low-fat diet, WT mice gained 
significantly more weight during the experiment than KO mice. Second, on high-fat diet, 
the average body weight gain was higher in WT mice than for KO mice, but there was 
no statistically significant difference. It is probable that having a greater sample size 
would have reduced the variance, and would have revealed a statistically significant dif-
ference in weight gain. Additionally, in both genotypes, weight gain increased approx-
imately 700% on high-fat diet when compared to low-fat diet. These data suggest that, 
through excessive weight gain, both genotypes may have developed obesity. 
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When analyzing the data, contrasting trends were apparent from weeks 9-11 and weeks 
12-18 of age, especially pertaining to high-fat diet. Figure 6 and Figure 7 show analyzed 
data from the two time periods where different trends became apparent.  
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Total Body Weight Gain: Weeks 1-3. Findings: There was a genotypic effect and a dietary 
effect Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD 
(45% kcal from fat) for 9 weeks. Body weight was measured twice a week. Statistics: Means are shown 
(± SEM). For diet: † p < 0.05; ††p < 0.01. 
 
 
 
 
 
 
 
 
 
 
Figure 7. Total Body Weight Gain: Weeks 4-9. Findings: There was a dietary effect. Methods: WT and 
MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal from fat) for 9 
weeks. Body weight was measured twice a week.  Statistics: Means are shown (± SEM). For diet: †p < 
0.05. 
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When evaluating total body weight gain in weeks 9 through 11, two-way ANOVA indi-
cated a genotypic effect (F1,14= 5.931; p = 0.029), a dietary effect (F1,14 = 74.447; p < 
0.001), but no effect on genotype x diet interaction (F1,14 = 1.173; p = 0.212). On both 
diets, there was a decreasing trend of KO mice weight gain when compared to WT mice. 
When compared to low-fat diet, both genotypes had a 400% higher weight gain on high-
fat diet.   
 
In contrast, Figure 7 shows differing trends compared to weeks 9-11.In regard to weeks 
12 through 18, two-way ANOVA indicated no genotypic effect (F1,14= 0.009; p = 0.924), 
no effect on genotype x diet interaction (F1,14 = 1.927; p = 0.187), but there was a dietary 
effect (F1,14 = 10.636; p = 0.006). Similar to previous weeks, KO mice on low-fat diet 
had tended to have a lower overall weight gain than WT mice on low-fat diet, with KO 
mice even experiencing a negative value in weight gain. In contrast to weeks 9-11, KO 
mice on high-fat diet tended to have a higher overall weight gain than WT mice on high-
fat diet. Additionally, the weight gain between WT mice on low-fat diet compared to 
high-fat diet was not statistically significantly different; however, the difference in 
weight gain between the KO groups was deemed statistically significant.  These data 
suggest that short-term, WT mice have a higher propensity for weight gain than KO 
mice, on either diet. In contrast, when placed on high-fat diet, long-term, KO mice may 
gain more weight than WT mice. 
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Food Intake Analysis. Average food intake of the four treatment groups, as seen in Fig-
ure 8, was analyzed over the 9 week experiment. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Food Intake. Findings: There was a genotypic effect, a dietary effect, an effect of time, and a 
genotype by diet interaction. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal 
from fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM). 
 
Three-way ANOVA indicated a genotypic effect ( F = 21.179 ; p < 0.001 ), a dietary ef-
fect ( F = 43.859 ; p < 0.001), an effect of time ( F = 14.488 ; p <0.001), and a genotype 
by diet interaction ( F = 4.003 ; p = 0.047), but no genotype by time interaction ( F = 
0.584 ; p = 0.809), no diet by time interaction ( F = 1.374 ; p = 0.205 ), and no interac-
tion of the three factors ( F = 0.064 ; p = 1.00). Food intake values were expected to be 
lower for high-fat diet, seeing as the food contains a higher caloric density. Interestingly, 
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on both diets, WT mice had higher food consumption than the KO mice. Table 4 illu-
strates significant differences at various weeks in the experiment. On a low-fat diet, KO 
mice consumed significantly less food than WT mice five out of the nine weeks of the 
experiment. While on high-fat diet, a similar difference was only seen at week twelve.  
 
 
 
  
 
 
 
 
 
 
 
Total food intake was calculated for each treatment group (Figure 9) and there were sig-
nificant differences between dietary and genotypic groups. 
 
 
 
 
 
 
Table 4. Food Intake (mg/week) 
Age WT/LF KO/LF WT/HF KO/HF 
(weeks)     
10 38.94 ± 3.41 28.23 ± 1.11* 34.56 ± 6.69 27.13 ± 3.58 
11 39.16 ± 3.55 27.85 ± 0.75* 27.94 ± 3.70 22.58 ± 2.24 
12 35.18 ± 3.02 26.93 ± 1.49 25.28 ± 1.53 20.93 ± 2.17* 
13 31.50 ± 1.48 25.15 ± 0.64* 20.94 ± 0.48†† 18.60 ± 1.55†† 
14 31.08 ± 1.21 25.70 ± 1.17* 23.44 ± 1.06†† 19.63 ± 1.63† 
15 41.02 ± 2.49 32.08 ± 1.32* 26.42 ± 0.90†† 24.98 ±1.32†† 
16 23.44 ± 1.66 18.38 ± 1.03 16.40 ± 1.83† 14.85 ± 3.29 
17 30.96 ± 5.15 24.33 ± 6.14 16.40 ± 1.83† 14.85 ± 3.29 
     
Total 329.56 ± 43.3 260.1 ± 7.03* 238.84 ± 25.12† 211.48 ± 15.18† 
Genotype : * P < 0.05  Diet : † P < 0.05; †† P < 0.01   
Means ± SEM are shown 
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Figure 9. Total Food Intake. Findings: There was a dietary effect. Methods: WT and MC5R KO mice 
(n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Food intake 
was measured twice a week. Statistics: Means are shown (± SEM). For genotype: *p < 0.05.  For diet: † p 
< 0.05. 
 
For total food intake, two-way ANOVA indicated no genotypic effect (F1,14= 2.73; p = 
0.1209), no effect on genotype x diet interaction (F1,14 = 0.52; p = 0.4846), but there was 
a dietary effect (F1,14 = 5.65; p = 0.0323). Compared to WT on low-fat diet, KO on low-
fat diet had a 30% lower food intake. Additionally, both genotypes experienced a signif-
icant decrease in total grams of food intake when on high-fat diet.  Under normal condi-
tions on a low-fat diet, KO mice consumed less food than WT mice. When fed a high-fat 
diet, there was no difference between WT and KO mice, but both genotypes experienced 
a decrease in food intake compared to low-fat diet.   
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Caloric Intake. Caloric intake was calculated by multiplying the food intake by kcal per 
gram of diet (Figure 10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Caloric Intake. Findings: There was a genotypic effect, a dietary effect, an effect of time. 
Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal 
from fat) for 9 weeks. Food intake was measured twice a week.  Statistics: Means are shown (± SEM). 
 
 
When analyzing caloric intake data, three-way ANOVA indicated a genotypic effect ( F 
= 17.973 ; p < 0.001 ), a dietary effect ( F = 13.795 ; p < 0.001), an effect of time ( F = 
14.127 ; p <0.001), but no genotype by diet interaction ( F = 41.115 ; p = 0.293), geno-
type by time interaction ( F = 0.587 ; p = 0.806), diet by time interaction ( F = 1.255 ; p 
= 0.267 ), and no interaction of the three factors ( F = 0.078 ; p = 1.00). On either diet, 
the MC5R KO mice did not appear to have as high a caloric intake as WT mice. Differ-
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ences between genotypes on the same diet were evident until week 15. The data suggests 
that MC5R and/or body size caused the KO mice to consume fewer calories than WT 
mice. Considering overlapping began to occur after week 15, we can speculate that if the 
experiment were lengthened, we might see the KO mice begin to consume similar or 
more calories than WT mice. Table 5 displays the genotypic and dietary significant dif-
ferences which appeared in 7 of the 9 weeks of the experiment.  
 
 
 
Total caloric intake (Figure 11) was then analyzed over the course of the 9 week experi-
ment. 
 
  
 
 
Table 5. Caloric Intake (kcal/week) 
Age WT/LF KO/LF WT/HF KO/HF 
(weeks)     
9 50.53 ± 4.77 41.77 ± 3.36 72.27 ± 5.65† 78.99 ± 13.47† 
10 120.71 ± 11.82 87.5 ± 3.45* 163.47 ± 35.4 128.3 ± 16.92 
11 121.4 ± 12.29 86.34 ± 2.34* 132.16 ± 19.59 106.78 ± 10.6 
13 109.06 ± 10.45 83.47 ± 4.62 119.57 ± 8.1 98.98 ± 10.26 
14 97.65 ± 5.15 77.97 ± 1.2* 99.04 ± 2.56 87.98 ± 7.34 
15 96.35 ± 4.21 79.67 ± 3.64* 110.87 ± 5.6 92.83 ± 7.69 
16 127.16 ± 8.63 99.44 ± 4.1* 124.97 ± 4.73 118.12 ± 6.24† 
     
Total 1021.64 ± 72.75 806.31  ± 22.52* 1129.71  ± 64.4  1000.28  ± 74.16† 
Genotype : * P < 0.05   Diet : † P < 0.05 
Means ± SEM are shown 
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Figure 11. Total Caloric Intake. Findings: There was a dietary effect and a genotypic effect. Methods: 
WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal from fat) 
for 9 weeks. Food intake was measured twice a week. Statistics: Means are shown (± SEM). For geno-
type: *p < 0.05.  For diet: † p < 0.05. 
 
For total caloric intake, two-way ANOVA indicated a genotypic effect (F1,14= 6.63; p = 
0.022), a dietary effect (F1,14 = 5.089; p = 0.041), but no genotype by diet interaction 
(F1,14 = 0.411; p = 0.532). On low-fat diet, KO mice had a 20% lower caloric intake than 
WT mice, while there was no difference between genotypes on high-fat diet. Additional-
ly, there was a 20% increase in caloric intake from KO mice on low-fat diet to KO mice 
on high-fat diet, but WT caloric intake was not altered by diet. This suggests that caloric 
intake levels are affected by MC5R, on low-fat diet and on high-fat diet. 
 
Feed Efficiency and Caloric Efficiency. Feed efficiency was calculated by taking the 
average weight gain divided by the average food intake. In Figure 12, feed efficiency is 
represented in grams. 
 
Total Caloric Intake
LF HF
0
500
1000
1500
2000 WT
KO
.
Fo
od
 In
ta
ke
 *
 k
ca
l
*
†
 33 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
Figure 12. Feed Efficiency (grams). Findings: There was a dietary effect, an effect of time, a diet by 
time interaction, and an interaction of the three factors. Methods: WT and MC5R KO mice (n = 4-5) were 
placed on LFD (14% kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Feed efficiency is calculated 
by body weight gain (g)/food intake (g). Statistics: Means are shown (± SEM). 
 
When analyzing feed efficiency over the 18 week experiment, three-way ANOVA indi-
cated dietary effect ( F = 37.283 ; p < 0.001), an effect of time ( F = 9.679 ; p < 0.001), a 
diet by time interaction ( F = 4.003 ; p = 0.047), and an interaction of the three factors ( 
F = 2.091 ; p = 0.034) . There was no genotypic effect ( F = 0.566 ; p = 0.453 ), no geno-
type by diet interaction ( F = 0.036 ; p = 0.850), and no genotype by time interaction ( F 
= 1.366 ; p = 0.209). Again, there appears to be a decline in feed efficiency from week 
16 to 18. This could be attributed to behavioral and/or ITT performed on the mice, with 
KO high-fat feed efficiency being most severely affected. 
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To normalize the feed efficiency results, caloric efficiency was calculated. The feed effi-
ciency data was then calculated by taking body weight divided by food intake, then mul-
tiplying the outcome by the calories provided by 1 gram of food (Figure 13). 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 13. Caloric Efficiency (kcals). Findings: There was a dietary effect, an effect of time, a diet by 
time interaction, and a diet, genotype, and time interaction. Methods: WT and MC5R KO mice (n = 4-5) 
were placed on LFD (14% kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Feed efficiency is cal-
culated by (body weight gain (g)/food intake (g)) * kcal. Statistics: Means are shown (± SEM). 
 
Three-way ANOVA indicated dietary effect ( F = 49.75 ; p < 0.001), an effect of  time ( 
F = 10.62 ; p < 0.001), a diet by time interaction ( F = 10.919 ; p < 0.001), and an inte-
raction of the three factors ( F = 1.968 ; p = 0.047) . There was no genotypic effect ( F = 
0.256 ; p = 0.614 ), no genotype by diet interaction ( F = 0.01 ; p = 0.919), and no geno-
Feed Efficiency (kcal)
8 9 10 11 12 13 14 15 16 17 18 19
-0.67
-0.52
-0.37
-0.22
-0.07
0.08
0.23
0.38
0.53
0.68
0.83 WT-LF
WT-HF
KO-HF
KO-LF
Age (weeks)
W
ei
gh
t G
ai
n(
g)
/F
oo
d 
In
ta
ke
(k
ca
l)
Caloric Ef iciency 
 35 
type by time interaction ( F = 1.527 ; p = 0.144). Similar outcomes to the feed efficiency 
measured in grams occurred. 
 
Significant difference in feed efficiency between the treatment groups were seen 8 out of 
the 9 weeks (Table 6). Genotypic differences were only displayed in the low-fat diet 
mice.  
 
 
 
 
 
 
 
 
 
 
 
Total feed efficiency was calculated in grams for the entirety of the experiment. There 
was indication of only significant differences between dietary groups. 
 
 
 
 
Table 6. Feed Efficiency 
Age WT/LF KO/LF WT/HF KO/HF 
(weeks)     
9 0.02 ± 0.01 0.03 ± 0.008 0.15 ± 0.03†† 0.17 ± 0.02†† 
10 0.03 ± 0.00 0.02 ± 0.003 0.06 ± 0.01† 0.05 ± 0.01† 
11 0.02 ± 0.00 0.02 ± 0.003 0.12 ± 0.02†† 0.06 ± 0.02† 
13 0.02 ± 0.01 -0.02 ± 0.004* 0.01 ± 0.03 0.02 ± 0.02 
15 0.03 ± 0.01 -0.01 ± 0.01*  0.05 ± 0.01 0.06 ± 0.03 
16 -0.01 ± 0.01 -0.01 ± 0.02 0.03 ± 0.03 0.09 ± 0.02†† 
17 0.03 ± 0.02 0.05 ± 0.027 -0.01 ± 0.02 -0.12 ± 0.07 
18 -0.01 ± 0.00  -0.001 ± 0.01  0.03 ± 0.02†† 0.06 ± 0.02†† 
     
Total 0.13 ± 0.09 0.07 ±0.09 0.48 ± 0.20†† 0.44 ± 0.24†† 
Genotype : * P < 0.05   Diet : † P < 0.05; †† P < 0.01   
Means ± SEM are shown 
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Figure 14. Total Feed Efficiency. Findings: There was a dietary effect Methods: WT and MC5R KO 
mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Feed 
efficiency is calculated by body weight gain (g)/food intake (g). Statistics: Means are shown (± SEM).  
For diet: † p < 0.05. 
 
Analysis of the total feed efficiency (Figure 14) calculated in grams by two-way 
ANOVA indicated no genotypic effect (F1,14= 0.33; p = 0.5754), no effect on genotype x 
diet interaction (F1,14 = 0.02; p = 0.8929), but there was a dietary effect (F1,14 = 21.05; p = 
0.0004). Overall, KO mice had a lower feed efficiency average than WT mice on both 
diets, but there were no statistically significant differences between the KO and WT 
mice. On high-fat diet, WT mice had a 400% higher feed efficiency than low-fat diet and 
KO mice had a 640% higher feed efficiency than low-fat diet. Although these data 
should be interpreted cautiously because there are two statistically significant differences 
and one intriguing trend, these data suggest that WT mice had a higher feed efficiency 
than KO mice and high-fat diet intake increases feed efficiency in both genotypes. 
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Behavioral Changes  
 
Behavioral data were collected. The data, however, were not included because behavior-
al study is out of the scope of energy balance. 
 
ITT Analysis 
 
Insulin Tolerance Testing is an indicator of mice’s sensitivity and/or resistance to insu-
lin. Each animal was subjected to an ITT analysis at 17 weeks of age and Figure 15 dis-
plays the results below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. ITT Analysis. Findings: There was an effect of time. Methods: WT and MC5R KO mice (n = 
4-5) injected with insulin (1U/kg) and tail vein blood was extracted at 0, 15, 30, 45, and 60 min. Glucose 
absorbency was measured using a glucose reagent. Statistics: Means are shown (± SEM). 
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 Three-way ANOVA indicated an effect of time ( F = 21.828 ; p = 0.006), a trend to-
wards a dietary effect ( F = 4.85 ; p = 0.092), but no genotypic effect ( F = 3.25 ; p = 
0.146). To normalize the data, the amount of glucose present was calculated as a percen-
tage of the initial glucose level. The higher the percentage of glucose present in the 
blood suggests a decline in glucose absorbency, signifying that the body has become less 
sensitive to insulin. The lower the percentage of glucose present, the higher the glucose 
permeability, denoting an elevation in insulin sensitivity. During the ITT, both low-fat 
diet groups maintained similar levels of insulin sensitivity. The KO low-fat diet treat-
ment group had a sharper initial decline in average glucose levels than the WT low-fat 
group, suggesting the KO mice reacted to the increase in insulin more rapidly. The low-
fat KO group also experienced lower average glucose levels up until the fourth time 
point. Overall, it appears that on low-fat diet, KO mice may have been more prone to 
having higher insulin sensitivity than WT mice. In contrast, on high-fat diet, both geno-
types experienced similar reactions to the increase in insulin up to the second time point. 
Throughout the time course, high-fat WT mice showed a significant decrease in insulin 
sensitivity, as was expected. Oppositely, high-fat diet KO mice showed maintenance of 
insulin sensitivity. KO mice on high-fat diet displayed similar glucose levels as the 
groups on low-fat diet, with the average glucose level at the ending time point being less 
than both low-fat genotypes. These findings suggest a major role of MC5R in insulin 
sensitivity development. When MC5R is present, obese mice develop insulin resistance, 
but when MC5R is deleted out of the mice’ genome, obese mice maintain insulin sensi-
tivity, and even may experience an increase in sensitivity if fed a high-fat diet long term.  
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RT-PCR Analysis 
 
Various gene expressions, involved in lipid metabolism, glucose metabolism, and insulin 
sensitivity, were analyzed using RT-PCR.  
 
Effects of High-fat Diet on PPARα mRNA Levels in Skeletal Muscle 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Effects of HFD on PPARα mRNA Levels in Skeletal Muscle. Findings: There was an effect 
of diet and a genotypic effect. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% 
kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of norma-
lized PFK-1 to GAPDH obtained in semi-quantitative RT-PCR. For diet: † p < 0.05. 
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Two-way ANOVA indicated a genotypic effect (F1,15= 6.459; p = 0.02) and a dietary 
effect (F1,15 = 7.12; p = 0.015), but no effect on genotype x diet interaction (F1,15 = 1.51; 
p = 0.234). Post Hoc analysis using Bonferroni’s t-test indicated that, compared to WT 
on low-fat diet, WT on high-fat diet had a 215% increase in PPARα mRNA levels. KO 
mice also experienced a 2-fold increase in PPARα mRNA levels, but there was no statis-
tically significant difference. Although KO PPARα mRNA skeletal muscle levels tended 
to decrease on both diets, no significant differences were apparent, and the high-fat diet 
group showed a trend toward a higher degree of difference than the low-fat diet (t = 
1.979; p = 0.083) (Figure 16).  Although these results should be interpreted cautiously, 
because there was one significant difference and two intriguing trends for dietary and 
genotypic differences that did not reach statistical significance, these data collectively 
suggest that MC5R and high-fat diet intake function as mediators of fatty acid oxidation 
in skeletal muscle, as seen by PPARα levels (1). 
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Effects of High-fat Diet on LCAD mRNA Levels in Skeletal Muscle 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Effects of HFD on LCAD mRNA Levels in Skeletal Muscle. Findings: There was an effect 
of diet. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD 
(45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to GAPDH 
obtained in semi-quantitative RT-PCR. 
 
Two-way ANOVA indicated there was no genotypic effect (F1,15= 0.283; p = 0.602), 
there was a dietary effect( F1,15 = 13.501; p = 0.002), but  no effect on genotype x diet  
interaction (F1,15=1.346; p = 0.264). Post Hoc analysis using Bonferroni’s t-test indicated 
that WT mice exhibited 400% higher LCAD mRNA levels in skeletal muscle on high-fat 
diet in contrast to low-fat diet. Similarly, relative to the low-fat diet, LCAD mRNA le-
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vels tended to increase 2.5-fold in the KO mice on the high-fat diet, but this trend was 
not statistically significant (t = 1.748; p = 0.131) (Figure 17). These data mutually pro-
pose that long chain fatty acid oxidation in skeletal muscle, as demonstrated by LCAD 
expression, increases more drastically in WT mice relative to MC5R KO mice on high-
fat diet (60).  
 
Effects of High-fat Diet on MCAD mRNA Levels in Skeletal Muscle 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Effects of HFD on MCAD mRNA Levels in Skeletal Muscle. Findings: There was an effect 
of diet. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD 
(45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to GAPDH 
obtained in semi-quantitative RT-PCR. For genotype: *p < 0.05. 
MCAD 
GAPDH 
Effects of High-Fat Diet
LF HF
0
1
2
3
4 WT
KO
.
Sk
el
et
al
 M
us
cl
eM
C
A
D
*
*
WT LF KO LF WT HF KO HF 
Effects of High-fat or Low-fat Diet 
 43 
Two-way ANOVA indicated there was no genotypic effect (F1,15 = 0.00; p = 0.945), 
there was a dietary effect (F1,15=31.55; p<0.001), but no effect on genotype x diet inte-
raction (F1,15 = 0.02; p = 0.885). Post Hoc analysis using Bonferroni’s t-test specified 
that relative to low-fat diet, both WT and KO genotypes exhibited 250% higher skeletal 
muscle MCAD mRNA levels on high-fat diet (Figure 18). These data collectively sug-
gest that medium chain fatty acid oxidation, as measured my MCAD expression, is sti-
mulated by in skeletal muscle by high-fat diet, independent of genotype (60). 
 
Effects of High-fat Diet on Akt1 mRNA Levels in Skeletal Muscle 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Effects of HFD on Akt1 mRNA Levels in Skeletal Muscle. Findings: There was an effect of 
diet. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% 
kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to GAPDH ob-
tained in semi-quantitative RT-PCR. 
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Two-way ANOVA indicated there was no genotypic effect (F1,14= 1.745; p = 0.208), 
there was a dietary effect (F1,14 = 7.49; p = 0.016), but no effect on genotype x diet inte-
raction (F1,14 = 0.043; p = 0.839). Post Hoc analysis using Bonferroni’s t-test indicated 
that, although Akt1 mRNA levels tended to increase in both WT and MC5R KO mice in 
skeletal muscle, there were no statistically significant differences. Both genotypic trends 
were nearly deemed statistically significant, with the KO mice having a greater dissimi-
larity: WT (t = -1.869; p = 0.094) and KO (t = -2.304; p = 0.069). It is plausible that hav-
ing a greater sample size would have reduced the variance, and would have revealed a 
statistically significant difference (Figure 19). Although these results should be inter-
preted cautiously, because there were two intriguing trends for dietary differences that 
did not reach statistical significance, these data collectively suggest that the trend in ele-
vation of Akt1, which inhibits apoptosis and plays a role in insulin sensitivity,  in skelet-
al muscle demonstrates a positive correlation between high-fat diet and cell growth (10, 
11). 
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Effects of High-fat Diet on AMPKa mRNA Levels in Skeletal Muscle 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. Effects of HFD on AMPKa mRNA Levels in Skeletal Muscle. Findings: There was an ef-
fect of diet. Methods: WT and MC5R KO mice(n = 4-5) were placed on LFD (14% kcal from fat) or HFD 
(45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to GAPDH 
obtained in semi-quantitative RT-PCR. For diet: † p < 0.05. 
 
Two-way ANOVA indicated there was no genotypic effect (F1,15= 1.11; p = 0.309), there 
was a dietary effect (F1,15 = 8.63; p = 0.010), but no effect on genotype x diet interaction 
(F1,15 = 0.00; p = 0.974).  Post Hoc analysis using Bonferroni’s t-test indicated that rela-
tive to WT and KO mice on low-fat diet, there was an increasing trend in AMPKa 
mRNA levels in skeletal muscle on high-fat diet. There was 250% higher AMPKa 
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mRNA levels in MC5R KO mice and comparably, AMPKa mRNA levels tended to in-
crease 4-fold on the high-fat diet in the WT mice, but this trend was not statically signif-
icant (t = -1.932; p = 0.085) (Figure 20). These data cooperatively infer a role for MC5R 
in the regulation of an enzyme, AMPKa, which is a central control point for energy ho-
meostasis, primarily fatty acid oxidation and glucose oxidation, in the cell (4, 70).  
 
Effects of High-fat Diet on PFK-1 mRNA Levels in Skeletal Muscle 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. Effects of HFD on PFK-1 mRNA Levels in Skeletal Muscle. Findings: There genotype by 
diet interaction. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or 
HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to 
GAPDH obtained in semi-quantitative RT-PCR. For genotype: **p < 0.01.  For diet: † p < 0.05. 
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Two-way ANOVA indicated that there was no genotypic effect (F1,15= 1.703; p = 0.213), 
no dietary effect (F1,15 = 2.945; p = 0.108), but there was a genotype x diet interaction 
(F1,15 = 12.603; p = 0.003). Post Hoc analysis using Bonferroni’s t-test indicated that 
relative to WT mice,MC5R KO mice exhibited 450% higher skeletal muscle PFK-1 
mRNA levels on the low-fat diet. By contrast, MC5R deficiency tended to reduce PFK-1 
mRNA levels 400% on the high-fat diet, but this trend was not statistically significant (t 
= 1.49; p = 0.186). It is plausible that having a greater sample size would have reduced 
the variance, and would have revealed a statistically significant difference. Additionally, 
PFK-1 mRNA levels tended to increase 3-fold on the high-fat diet in the WT mice, when 
compared to KO high-fat diet levels, but this trend was not statistically significant (t = 
1.389; p = 0.198). By contrast, PFK-1 mRNA levels were reduced by high-fat diet in the 
KO mice (Figure 21). Although these results should be interpreted cautiously, because 
there were two significant differences and two intriguing trends for genotypic and dieta-
ry differences that did not reach statistical significance, these data suggest a major role 
for MC5R in the regulation of a rate-limiting enzyme, PFK-1, for glycolysis in the ske-
letal muscle (72).   
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Effects of High-fat Diet on PPARα mRNA Levels in Liver 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. Effects of HFD on PPARα mRNA Levels in Liver. Findings: There was an effect of geno-
type, and an effect of diet. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal 
from fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized 
PFK-1 to GAPDH obtained in semi-quantitative RT-PCR. For genotype: *p < 0.05.  For diet: † p < 0.05. 
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Two-way ANOVA indicated a genotypic effect (F1, 14 = 6.433; p = 0.024), a dietary ef-
fect (F1,14= 6.210; p = 0.026, but no genotype x diet interaction (F1,14 = 0.068; p = 0.798). 
Post Hoc analysis using Bonferroni’s t-test indicated that, on high-fat diet, there was a 2-
fold decrease in KO PPARα mRNA levels in liver compared to WT mice. On low-fat 
diet, KO mRNA levels similarly trended downward, but there was no statistically signif-
icant difference (t = 1.503; p = 0.177). Within genotypes, both WT and KO PPARα le-
vels decreased on high-fat diet, but only KO mice showed a statistically significant dif-
ference, decreasing by 200%. Having a greater sample size might have reduced the va-
riance, revealing a statistically significant difference where trends are apparent (Figure 
22). Although these outcomes should be interpreted carefully, because there are two sig-
nificant differences and two intriguing trends for dietary and genotypic that did not reach 
statistically significant differences, these data collectively suggest that MC5R has a 
function in regulating PPARα, a receptor critically involved in controlling FAO in liver 
(32). 
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Effects of High-fat Diet on LCAD mRNA Levels in Liver 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Effects of HFD on LCAD mRNA Levels in Liver. Findings: There was an effect of diet. 
Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal 
from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to GAPDH obtained in 
semi-quantitative RT-PCR. For diet: † p < 0.05. 
 
Two-way ANOVA indicated no genotypic effect (F1,16= 1.781; p = 0.201), no genotype 
x diet interaction (F1,16 = 0.959; p = 0.342), but there was a dietary effect (F1,16 = 8.751; p 
= 0.009).  Post Hoc analysis using Bonferroni’s t-test indicated that, when compared to 
low-fat diet, high-fat diet WT mice LCAD mRNA levels decreased 100% in liver. Al-
though there also appears to be a decreasing trend in KO mice on high-fat diet, there was 
no statistical difference (Figure 23). These data collectively suggest that, contrasting to 
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its relative MCAD, LCAD, which is a marker for long chain fatty acid oxidation, may be 
regulated further by fat intake, rather than MC5R (60). 
 
Effects of High-fat Diet on MCAD mRNA Levels in Liver 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 24. Effects of HFD on MCAD mRNA Levels in Liver. Findings: There was an effect of diet. 
Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal 
from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to GAPDH obtained in 
semi-quantitative RT-PCR. 
 
Two - way ANOVA indicated no genotypic effect (F1,16= 2.499; p = 0.133), no genotype 
x diet interaction (F1,16 = 1.028; p = 0.326), but there was a dietary effect (F1,16 = 5.834; p 
= 0.028). Although Post Hoc analysis using Bonferroni’s t-test indicated that MCAD 
mRNA levels tended to decrease in both WT and MC5R KO mice on high-fat diet in 
liver, there were no statistically significant differences, the highest difference in the WT 
(t = 2.142; p = 0.061).  Additionally, the KO mice had reduced MCAD mRNA levels on 
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both diets, relative to WT mice, but there were no statistically significant differences. It 
is plausible that having a greater sample size would have reduced the variance, and 
would have revealed a statistically significant difference (Figure 24). Although these re-
sults should be interpreted cautiously, because there were two intriguing trends for geno-
typic and dietary differences that did not reach statistical significance, these data collec-
tively suggest that both fat intake and MC5R may play a small role in the regulation of a 
marker of fatty acid oxidation of medium chain fatty acids, MCAD (60). 
 
Effects of High-fat Diet on FGF-21 mRNA Levels in Liver 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. Effects of HFD on FGF-21 mRNA Levels in Liver. Findings: There was an effect of diet, 
and a genotype by diet interaction. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD 
(14% kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of 
normalized PFK-1 to GAPDH obtained in semi-quantitative RT-PCR. For genotype: *p < 0.05. 
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Two-way ANOVA indicated there was no genotypic effect (F1,16= 2.178; p = 0.159), but 
there was a dietary effect (F1,16 = 10.619; p = 0.005) and a genotype x diet interaction 
(F1,16 = 7.108; p = 0.017).  Post Hoc analysis using Bonferroni’s t-test indicated that, rel-
ative to WT mice, Fgf-21 mRNA levels were reduced in the KO mice on low-fat diet, 
but this trend was not statistically significant (t = 1.169; p = 0.125). By contrast, FGF-21 
mRNA levels in liver were 200% higher in KO mice on high-fat diet when compared to 
WT mice. Additionally, WT mice FGF-21 mRNA levels in liver were relatively unal-
tered when comparing diets, but, relative to low-fat diet, MC5R KO mice exhibited an 
800% higher AKT1 mRNA level in liver on high-fat diet (Figure 25). Although these 
results should be interpreted cautiously, because there is one significant difference and 
one intriguing trends for genotypic and dietary differences that did not reach statistical 
significance, these data collectively suggest a putative role for MC5R in the regulation 
of a metabolic protein, FGF-21, critically involved in fatty acid oxidation and/or insulin 
sensitivity (71). 
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Effects of High-fat Diet on Akt1 mRNA Levels in Liver 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 26. Effects of HFD on Akt1 mRNA Levels in Liver. Findings: There was an effect of diet and a 
genotype by diet interaction. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal 
from fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized 
PFK-1 to GAPDH obtained in semi-quantitative RT-PCR. For genotype: **p < 0.01.  For diet:  ††p < 
0.01. 
 
Two-way ANOVA indicated there was no genotypic effect (F1,16= 1.65; p = 0.217), but 
there was a dietary effect (F1,16 = 9.83; p = 0.006) and a genotype x diet interaction (F1,16 
= 11.254; p = 0.004). Post Hoc analysis using Bonferroni’s t-test indicated that, relative 
to WT mice, Akt1 mRNA levels were reduced in the KO mice on low-fat diet, but this 
trend was not statistically significant (t = 1.185; p = 0.267). By contrast, Akt1 mRNA 
levels in liver were 300% higher in KO mice on high-fat diet when compared to WT 
mice. Additionally, WT mice AKT1 mRNA levels in liver were unaltered when compar-
ing diets, but, relative to low-fat diet, MC5R KO mice exhibited a 600% higher AKT1 
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mRNA level in liver on high-fat diet (Figure 26).  There were two significant differences 
and one intriguing trend for genotypic and dietary differences that did not reach statistic-
al significance. These data collectively suggest that MC5R may be a major regulator of 
Akt1, and glucose metabolism and insulin activity, in the liver (69). 
 
Effects of High-fat Diet on PFK1 mRNA Levels in Liver 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 27. Effects of HFD on PFK-1 mRNA Levels in Liver. Findings: There were no dietary or geno-
typic effects. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or 
HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to 
GAPDH obtained in semi-quantitative RT-PCR. 
 
Two-way ANOVA indicated no genotypic effect (F1,16= 2.394; p = 0.141), no dietary 
effect (F1,16 = 0.661; p = 0.428), and no genotype x diet interaction (F1,16 = 0.048; p = 
0.830). Post Hoc analysis using Bonferroni’s t-test indicated that, although PFK-1 
mRNA levels in the liver tended to decrease in KO mice relative to WT mice, on low-fat 
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diet and high-fat diet, the trends were not statistically significant: low-fat diet (t = 0.932; 
p = 0.376) and high-fat diet (t = 1.305; p = 0.233). It is plausible that having a greater 
sample size would have reduced the variance, and would have revealed a statistically 
significant difference (Figure 27). Although these results should be interpreted cautious-
ly, because there were two intriguing trends for genotypic differences that did not reach 
statistical significance, these data collectively suggest that MC5R may play a diminutive 
role in the regulation of a rate-limiting enzyme, PFK-1, for glycolysis in the liver (35). 
 
Effects of High-fat Diet on HSL mRNA Levels in Liver 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. Effects of HFD on HSL mRNA Levels in Liver.  Findings: There was an effect of diet. Me-
thods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal 
from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to GAPDH obtained in 
semi-quantitative RT-PCR. For diet: † p < 0.05. 
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Two-way ANOVA indicated no genotypic effect (F1,16= 0.053; p = 0.821), no genotype 
x diet interaction (F1,16 = 0.844; p = 0.372), but there was a dietary effect (F1,16 = 12.544; 
p = 0.003).  Post Hoc analysis using Bonferroni’s t-test indicated that while there were 
no differences between genotypes on low-fat diet or high-fat diet, high-fat diet adminis-
tration did cause a decline in HSL levels in liver (Figure 28). On high-fat diet, WT mice 
experienced a 300% decrease in HSL mRNA levels when compared to WT on low-fat 
diet. Similarly, MC5R KO mice had a 200% decrease in HSL levels, but there was no 
statistical significance (t = 1.863; p = 0.105). Although this data should be interpreted 
carefully because there was one significant difference and one similar trend for genotyp-
ic and dietary differences that did not reach statistical significance, this data suggests 
that fat accumulation from excess dietary fat may regulate hormone sensitive lipase, or 
HSL, an enzyme responsible for breaking down fatty acids. MC5R does not appear to 
play a large role in controlling HSL (18). 
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Effects of High-fat Diet on DGAT2 mRNA Levels in Liver 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. Effects of HFD on DGAT2 mRNA Levels in Liver. Findings: There was a genotypic effect. 
Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal 
from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to GAPDH obtained in 
semi-quantitative RT-PCR. For genotype: *p < 0.05. 
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Two-way ANOVA indicated a genotypic effect (F1,16 = 5.772; p = 0.029),but no dietary 
effect (F1,16 = 0.031; p = 0.863), and no genotype x diet interaction (F1,16 = 2.678; p = 
0.121),  Post Hoc analysis using Bonferroni’s t-test indicated that on both diets, MC5R 
KO mice expressed higher mRNA levels of DGAT2 than WT mice (Figure 29). While 
no significance was shown between WT and KO low-fat diet levels, on high-fat diet, the 
KO mice had a 250 % higher level of DGAT2 mRNA expression than WT. Additional-
ly, WT mice showed a decrease in DGAT2 mRNA levels from low-fat to high-fat diets, 
but this value was not statistically significant ( t = 21.00 ; p = 0.126 ). In contrast to WT, 
KO mice tended to have an increase in level when administered high-fat diet. Although 
these effects should be translated with caution, because there was one significant differ-
ence and two intriguing trends for genotypic and dietary differences that did not reach 
statistical significance, these data collectively suggest that MC5R plays a role in regulat-
ing adipose storage, as seen by DGAT2 mRNA expression, in the liver (42). 
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Effects of High-fat Diet on PPARγ mRNA Levels in Omental Fat 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30. Effects of HFD on PPARγ mRNA Levels in Omental Fat. Findings: There was no effect of 
diet, genotype, or interaction. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% 
kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of norma-
lized PFK-1 to GAPDH obtained in semi-quantitative RT-PCR.  For diet: ††p < 0.01. 
 
Two-way ANOVA indicated there was no genotypic effect (F1,13= 1.36; p = 0.265),  no 
dietary effect (F1,13 = 0.089; p = 0.770), and no genotype x diet interaction (F1,13 = 0.118; 
p = 0.736). WT PPARγ mRNA levels appeared to be unaltered by diet, but KO mice le-
vels were consistently lower than WT on both diets. Additionally, Post Hoc analysis us-
ing Bonferroni’s t-test indicated that there was a statistically significant increase in 
PPARγ mRNA levels in KO mice on high-fat diet compared to low-fat diet (Figure 30). 
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These data collectively suggest that MC5R and dietary fat intake can alter PPARγ, 
which, when activated in adipose, serves as a stimulant of whole body insulin sensitivity 
and adipogenesis, and lipid storage (36, 52, 68). 
 
Effects of High-fat Diet on LCAD mRNA Levels in Omental Fat 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31. Effects of HFD on LCAD mRNA Levels in Omental Fat. Findings: There was no effect of 
diet, genotype, or interaction. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% 
kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of norma-
lized PFK-1 to GAPDH obtained in semi-quantitative RT-PCR. 
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Two-way ANOVA indicated there was no genotypic effect (F1,12= 0.413; p = 0.533), no 
dietary effect (F1,12 = 1.128; p = 0.309), and no genotype x diet interaction (F1,12 = 0.042; 
p = 0.841). ). Although there were no statistical differences between WT and KO Akt1 
mRNA levels on low-fat diet or high-fat diet, high-fat diet intake appeared to increase 
LCAD mRNA levels in both WT and KO mice (Figure 31). These data suggest that die-
tary fat intake, but not MC5R, may play a small role in regulating fatty acid oxidation by 
stimulating LCAD in adipose tissue (47). 
 
 
Effects of High-fat Diet on MCAD mRNA Levels in Omental Fat 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32. Effects of HFD on MCAD mRNA Levels in Omental Fat. Findings: There was no effect of 
diet, genotype, or interaction. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% 
kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of norma-
lized PFK-1 to GAPDH obtained in semi-quantitative RT-PCR. 
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Two-way ANOVA indicated there was no genotypic effect (F1,13= 0.208; p = 0.656), no 
dietary effect (F1,13 = 2.858; p = 0.115), and no genotype x diet interaction (F1,13 = 0.00; 
p = 0.985). High-fat diet intake appeared to increase MCAD mRNA levels in both WT 
and KO mice, but there were no statistical differences between WT and KO Akt1 mRNA 
levels on low-fat diet or high-fat diet (Figure 32). These data suggest that dietary fat in-
take, but not MC5R, may play a small role in regulating fatty acid oxidation by stimulat-
ing MCAD in adipose tissue (47). 
 
Effects of High-fat Diet on Akt1 mRNA Levels in Omental Fat 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33. Effects of HFD on Akt1 mRNA Levels in Omental Fat. Findings: There was no effect of 
diet, genotype, or interaction. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% 
kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of norma-
lized PFK-1 to GAPDH obtained in semi-quantitative RT-PCR.  
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Two - way ANOVA indicated there was no genotypic effect (F1,13= 0.514; p = 0.486), a 
trend towards a dietary effect (F1,13 = 3.792; p = 0.073), and no genotype x diet interac-
tion (F1,13 = 0.724; p = 0.410). There were no statistical differences between WT and KO 
Akt1 mRNA levels on low-fat diet and high-fat diet (Figure 33). These data suggest that 
Akt1, a gene involved in insulin activity, expression in adipose tissue is not affected by 
MC5R or dietary fat intake (31).  
 
Effects of High-fat Diet on SREBP1c mRNA Levels in Omental Fat 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34. Effects of HFD on SREBP1c mRNA Levels in Omental Fat. Findings: There was no effect 
of diet, genotype, or interaction. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% 
kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of norma-
lized PFK-1 to GAPDH obtained in semi-quantitative RT-PCR. For diet: † p < 0.05. 
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Two-way ANOVA indicated there was no genotypic effect (F1,13= 0.469; p = 0.505) and 
no genotype x diet interaction (F1,13 = 2.45; p = 0.142), but there was a trend towards a 
dietary effect (F1,13 = 4.413; p = 0.056). Although there were no statistically significant 
differences between WT and KO mice on either diet, on low-fat diet, KO mice 
SREBP1c mRNA levels tended to decrease while on high-fat diet, KO mice levels 
tended to increase, each compared to WT. Additionally, Post Hoc analysis using Bonfer-
roni’s t-test indicated that there was a 280% increase in KO SREBP1c mRNA levels on 
high-fat diet when compared to low-fat diet (Figure 34). Although these results should 
be interpreted cautiously, because there was one significant difference and one intriguing 
trend for genotypic and dietary differences that did not reach statistical significance, 
these data collectively suggest that MC5R may aid in regulating an enzyme, SREBP1c,  
which is stimulated by insulin and serves as the primary transcription factor for lipoge-
nesis in adipose tissue (14, 38, 52). 
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Effects of High-fat Diet on PPARγ mRNA Levels in BAT 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 35. Effects of HFD on PPARγ mRNA Levels in BAT. Findings: There was an effect of diet. 
Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal 
from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to GAPDH obtained in 
semi-quantitative RT-PCR. For genotype: *p < 0.05. 
 
Two-way ANOVA indicated although there was no genotypic effect (F1,14= 1.022;  p = 
0.329), and no genotype x diet interaction (F1,14 = 1.488; p = 0.243), there was a dietary 
effect (F1,14 = 7.246; p = 0.018). Post Hoc analysis using Bonferroni’s t-test indicated 
that there was a 200% decrease in PPARγ mRNA levels in WT mice on high-fat diet and 
a 400% decrease in KO mice on high-fat diet, when compared to low-fat diet, in BAT. 
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On low-fat diet, KO mice expressed higher levels of PPARγ than WT mice, but there 
was no statistically significant differences (t = -1.135; p = 0.294) (Figure 35). It is rea-
sonable that having a greater sample size would have reduced the variance, and would 
have revealed a statistically significant difference. These data suggest that high-fat diet 
intake may possibly alter the activity of PPARγ, an enzyme stimulated by insulin and 
involved in adipogenesis in BAT (67, 68).   
 
Effects of High-fat Diet on LCAD mRNA l Levels in BAT 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36. Effects of HFD on LCAD mRNA Levels in BAT. Findings: There was a dietary effect. Me-
thods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from 17) or HFD (45% kcal 
from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to GAPDH obtained in 
semi-quantitative RT-PCR. 
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Two-way ANOVA indicated there was no genotypic effect (F1,14=0.210; p = 0.653), 
there was a dietary effect (F1,14 = 5.118; p = 0.04), but no genotype x diet interaction 
(F1,14 = 3.112; p = 0.100). Within the diet groups, there were contrasting trends of LCAD 
mRNA levels. In low-fat diet, KO mice had higher LCAD mRNA levels than WT mice, 
but on high-fat diet, KO mice exhibited lower levels than WT mice, and this difference 
was almost deemed statistically significant (t = 2.354; p = 0.051). Additionally, KO mice 
on high-fat diet had a 3-fold decrease in LCAD levels when compared to low-fat diet, 
but there was no statistically significant difference (t = 2.004; p = 0.092) (Figure 36). It 
is plausible that having a greater sample size would have reduced the variance, and 
would have revealed a statistically significant difference. These outcomes should be in-
terpreted carefully because there were two intriguing trends for genotypic and dietary 
differences that did not reach statistical significance. In conclusion, these data collective-
ly suggest that MC5R could play a role in the control of long chain fatty acid oxidation 
in BAT, as seen by varying LCAD levels (73). 
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Effects of High-fat Diet on MCAD mRNA Levels in BAT 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37. Effects of HFD on MCAD mRNA Levels in BAT. Findings: There was an effect of diet, 
genotype, and an interaction of the two. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD 
(14% kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of 
normalized PFK-1 to GAPDH obtained in semi-quantitative RT-PCR. For genotype: *p < 0.05.  For diet: 
† p < 0.05. 
 
Two-way ANOVA indicated a genotypic effect (F1,14= 7.634; p = 0.015), there was a 
dietary effect (F1,14 = 19.848; p < 0.001), and a genotype x diet interaction (F1,14 = 10.91; 
p = 0.005). Post Hoc analysis using Bonferroni’s t-test indicated that, on low-fat diet, 
KO mice had a 400% higher in MCAD mRNA levels in BAT than WT mice. In contrast, 
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WT and KO mRNA levels were similar on high-fat diet. Additionally, WT mice on 
high-fat diet had a 500% increase in mRNA MCAD BAT levels when compared to low-
fat diet (Figure 37). These data suggest that MC5R may have a large role in the regula-
tion of MCAD, a marker for FAO, specifically medium chain fatty acid oxidation, in 
BAT (67).  
 
Effects of High-fat Diet on FGF-21 mRNA Levels in BAT 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38. Effects of HFD on FGF-21 mRNA Levels in BAT. Findings: There was a dietary effect. 
Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from fat) or HFD (45% kcal 
from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 to GAPDH obtained in 
semi-quantitative RT-PCR.  For diet: † p < 0.05. 
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Two-way ANOVA indicated there was no genotypic effect (F1,14= 0.309; p = 0.587), 
there was a dietary effect (F1,14 = 8.088; p = 0.013), but no genotype x diet interaction 
(F1,14 = 0.008; p = 0.929). Post Hoc analysis using Bonferroni’s t-test indicated that there 
was a 2.5 fold increase in FGF-21 mRNA levels in WT mice on high-fat diet, when 
compared to low-fat diet, in BAT. Additionally, evaluated against low-fat diet, KO mice 
on high-fat diet expressed a 3.5 fold increase in FGF-21 mRNA levels, but there was no 
statistically significant differences (t = -1.620; p = 0.156) (Figure 38). It is plausible that 
having a greater sample size would have reduced the variance, and would have revealed 
a statistically significant difference. Although these results should be interpreted cau-
tiously, because there was one significant difference and one intriguing trend for dietary 
differences that did not reach statistical significance, these data collectively suggest that 
dietary fat intake, but not MC5R, may not play a large role in regulating FGF-21, a key 
player in fatty acid oxidation and thermoregulation, in BAT (26). 
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Effects of High-fat Diet on Akt1 mRNA Levels in BAT 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39. Effects of HFD on Akt1 mRNA Levels in BAT. Findings: There was no effect of diet, geno-
type, or interaction. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD (14% kcal from 
fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of normalized PFK-1 
to GAPDH obtained in semi-quantitative RT-PCR. 
 
Two-way ANOVA indicated no genotypic effect (F1,14= 0.12; p = 0.734), no genotype x 
diet interaction (F1,14 = 0.551; p = 0.470), but a trend towards a dietary effect (F1,14 = 
3.841; p = 0.071). Although there appeared to be a tendency for a decrease in Akt1 
mRNA levels in BAT in both genotypes on high-fat diet, there were no statistically sig-
nificant differences (WT: t = 2.008; p = 0.08 and KO: t = 1.259; p = 0.255) (Figure 39). 
Although these results should be interpreted cautiously, because there were two intri-
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guing trend for dietary differences that did not reach statistical significance, these data 
collectively suggest that dietary fat intake, and not MC5R, may play a role in regulating 
the gene Akt1, which may be required for insulin regulation of glucose uptake and lipo-
genesis in BAT (65). 
 
Effects of High-fat Diet on SREBP1c mRNA Levels in BAT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40. Effects of HFD on SREBP1c mRNA Levels in BAT. Findings: There was no effect of diet, 
genotype, or an interaction of the two. Methods: WT and MC5R KO mice (n = 4-5) were placed on LFD 
(14% kcal from fat) or HFD (45% kcal from fat) for 9 weeks. Statistics: Means are shown (± SEM) of 
normalized PFK-1 to GAPDH obtained in semi-quantitative RT-PCR. 
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Two-way ANOVA indicated there was no genotypic effect (F1,14= 1.836; p = 0.197), no 
dietary effect (F1,14 = 2.117; p = 0.168), and no genotype x diet interaction (F1,14 = 2.721; 
p = 0.121). Although there were no statistical differences between WT and KO 
SREBP1c mRNA levels on low-fat diet or high-fat diet, KO mice on low-fat diet tended 
to express a 200% higher level of SREBP1c mRNA than WT mice on low-fat diet 
(Figure 40). These data suggest that MC5R may play a role in regulating the enzyme 
SREBP1c, which is involved in adipocyte differentiation and lipogenesis (62).  Multiple 
gene expressions in the four tissues analyzed were significantly altered by MC5R, dieta-
ry fat, or both. Table 7 displays genes whose expression was significantly changed.  
 
 
Table 7. Significantly Altered Genetic Expressions 
Genes          Skeletal Muscle               Liver                  Omental Fat               BAT  
Analyzed      (-)MC5R    HF Diet       (-)MC5R    HF Diet         (-)MC5R   HF Diet       (-)MC5R  HF Diet 
 PPARα  
 
    
LCAD   
 
    
MCAD      
 
DGAT2   
 
    
HSL   
 
    
FGF-21   
 
   
PPARγ     
  
SREBP1c   
 
   
Akt1        
AMPKa 
 
      
PFK-1 
 
      
        : increase/decrease in WT expression                 : increase/decrease in MC5R KO expression 
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DISCUSSION 
 
Tissue Weights 
 
Each tissue was weighed directly after extraction. Interestingly, liver weights differed 
between genotypes and diets. The liver plays an imperative role in fatty acid oxidation 
and glucose metabolism. On both diets, KO mice had a smaller liver than WT mice, and 
KO mice experienced a significant growth in liver mass on high-fat diet, when WT mice 
did not. Similar to liver, kidneys hold responsibility in lipid metabolism. On both diets, 
KO mice had smaller average kidney sizes than WT mice, especially on the low-fat diet. 
When administered high-fat diet, both genotypes experienced an increase in kidney size, 
but only the KO mice showed a statistically significant elevation. The differences in siz-
es of livers and kidneys between WT and KO mice suggest alterations in fat metabolism 
between diets and genotypes. The deletion of MC5R might cause the KO mice to either 
metabolize fat at a higher rate or not store fat at as high a capacity as WT mice. When 
given a high-fat diet, only the KO mice experienced a significant increase in liver and 
kidney size. While the WT’s continued to burn fat at a similar rate to the mice on low-fat 
diet, the KO mice might have been required to alter the method by which they metabol-
ize fat in order to maintain body lipid homeostasis. In contrast to liver size patterns, the 
pancreas weight was similar in KO mice and WT mice on low-fat diet, but showed a 
significant enlargement in both genotypes on high-fat diet. Additionally, the pancreas of 
the KO on high-fat diet was larger than the pancreas of the WT on an identical diet. The 
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pancreas is responsible for releasing digestive enzymes to break down carbohydrates and 
glucose metabolism hormones such as glucagon and insulin.  The preputial glands, 
which are also responsible for releasing hormones into the body, were also affected by 
MC5R. Overall, the preputial glands of the KO mice were smaller in size than the prepu-
tial glands of the WT mice. When on high-fat diet, the glands of the WT mice tended to 
increase, and KO mice glands did not, creating a significant difference between geno-
types on high-fat diet. Skeletal muscle weight did not differ between genotypes on either 
diet, but KO mice had an average larger skeletal muscle weight on high-fat diet when 
compared to low-fat diet. WT mice experienced no difference. The higher weight in ske-
letal muscle might be due to the decrease in FAO occurring in the muscle when MC5R 
is not present.  
 
All fat pads in both genotypes were significantly different on high-fat diet. The elevation 
in each fat pad weight suggests that both MC5R KO mice and WT mice developed an 
obese phenotype by the completion of the study. The only genotypic difference that oc-
curred was in the omental fat region. While the KO and WT mice had similar omental 
fat weights on low-fat diet, the WT mice experienced a greater increase in omental fat on 
high-fat diet. This created a greater significance between WT low-fat diet and WT high-
fat diet groups, and also suggested a significant decrease between WT mice on high-fat 
diet and KO mice on high-fat diet. Interestingly, the omental fat region is most highly 
associated with obesity and cardiometabolic diseases. The decrease in adipose tissue in 
the omental region when MC5R is absent is another way MC5R may affect metabolism. 
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Overall, the presence of MC5R appears to have an effect on the metabolism, and there-
fore the tissue weights, of the mice. 
 
Body Weight, Food Intake, and Caloric Efficiency 
 
Body weight was measured twice a week for the duration of the experiment. After ana-
lyzing the body weight data, significant differences appeared not only in overall body 
weight gain, but in the body weight gain patterns of the four treatment groups. When fed 
a low-fat diet, both genotypes had similar weight gain, even though on low-fat diet, KO 
mice had significantly lower average initial weights than WT mice. In contrast, when the 
mice were fed high-fat diet, WT mice exhibited an overall higher weight gain than KO 
mice. When analyzing the data, a difference in trends appeared. There was a distinct 
time point in which the KO mice began gaining more weigh on high-fat diet than WT 
mice. During weeks nine through eleven, WT mice gained more weight than the KO 
mice on high-fat diet. In contrast, during weeks twelve through eighteen, which is the 
majority of the experiment, KO mice gained more weight than WT mice on high-fat diet. 
The data suggest that in the short-term, WT mice have a higher propensity for weight 
gain than KO mice, on either diet. In contrast, when placed on high-fat diet, long-term, 
KO mice might gain weight than WT mice. Another aspect taken into account when 
looking at body weight gain is the decline in weight gains from week 16 to 18 in the 
high-fat diet groups, particular the MC5R KO mice. The alteration in the direction of 
weight gain could be attributed to the behavioral and ITT done on the mice. First, week 
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sixteen’s behavioral testing might have been the cause of the slight drop in weight gain 
for both genotypes. Second, week 17’s ITT might have continued the negative affect on 
weight gain for both genotypes, with KO weight gain decreasing more severely than WT 
weight gain. This suggests that different stimuli affects KO mice, in both diet groups, 
more largely than WT mice. The difference in rates of weight gain between KO and WT 
groups suggest that MC5R again plays a role in lipid metabolism and/or glucose meta-
bolism. 
 
Food intake analysis displayed multiple significant differences as well. Over the course 
of the experiment, on low-fat diet, MC5R KO mice ate significantly less than WT mice, 
but when fed high-fat diet the two groups intakes were similar. As expected, both geno-
types had a significant decline in overall food intake compared to the low-fat diet groups 
when given the higher calorie high-fat diet. The smaller body size of the KO mice might 
have been the cause of the lesser food intake or vice versa. Similar to body weight, food 
intake for each treatment group declined in response to the behavior testing during week 
sixteen. Low-fat diet group’s food intake levels increased to previous levels after the 
testing and continued to increase during ITT on week seventeen. In contrast, both geno-
types on high-fat diet had a decrease in food intake after behavior testing, and had a con-
tinued decline during week seventeen after ITT. Dietary fat content affected \food con-
sumption after the insulin increase in their system.  
 
 79 
Caloric intake and overall feed efficiency was the highest for the high-fat diet groups. 
Caloric intake analysis suggests that MC5R plays a role in regulating the quantity of cal-
ories the mouse consumes. On low-fat diet, the KO mice had significantly lower caloric 
intake than WT, and when administered high-fat diet, the WT mice experienced a non-
significant increase in caloric intake while KO mice had a significant increase of 20%. 
While the data also suggests that WT mice may have a higher feed efficiency than KO 
mice and high-fat diet intake increases feed efficiency in both genotypes, inspecting the 
feed efficiency weekly displays an interesting alternative. For the majority of the expe-
riment, the KO high-fat diet group appears to have had a higher feed efficiency than the 
WT group on high-fat diet. If weeks sixteen and seventeen were excluded, KO mice may 
have had the highest feed efficiency. The data suggests that while MC5R KO mice 
showed a greater response to behavioral and metabolic stimulation, they may also exhi-
bited a higher rate of feed efficiency over a long term experiment.  
 
ITT Analysis 
 
The ITT analysis results suggest a major role of MC5R in insulin sensitivity and resis-
tance. While there was a slight difference in the way MC5R KO mice and WT mice 
handle excess insulin, the difference was exaggerated when the mice are placed on high-
fat diet. When MC5R was present, obese mice develop insulin resistance as expected, 
but when MC5R was absent, the KO obese mice maintained insulin sensitivity. Further, 
if the trend were to continue, a long term study in which MC5R KO mice are placed on 
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high-fat diet may show an increase in insulin sensitivity in the KO mouse. This finding 
is significant in that MC5R may play a role in the dissociation between obesity and insu-
lin resistance.   
 
RT-PCR Results 
 
Skeletal muscle is a primary figure in metabolic activity (1). One metabolic gene, 
MCAD, which stimulates medium chain fatty acid oxidation, was stimulated by high-fat 
diet in skeletal muscle. Instead of being stored in tissue, medium chain fatty acids are 
transported throughout the body and swiftly oxidized into ketones, increasing energy 
expenditure (60). MC5R exhibited no effect on the activity of MCAD and therefore had 
no effect on the amount of circulating and oxidized fat in the skeletal muscle. LCAD, 
which stimulates the oxidation of long chain fatty acids, was slightly affected by the 
presence of MC5R (60). High-fat diet stimulated LCAD in both genotypes, with WT 
mice having had a greater increase than KO mice, but neither showed a statistically sig-
nificant difference. The KO mice exhibited a tendency to express LCAD, and therefore 
FAO, at lower levels on high-fat diet. Long chain fatty acids are stored as adipose, and 
the trend of LCAD mRNA expression to increase in the both groups on high-fat diet 
suggest that the presence of excess fat in the diet increased the oxidation of fat in the 
skeletal muscle.  
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Not only does MCAD and LCAD show that fat oxidation increased in skeletal muscle 
with the presence of MC5R, PPARα expression provides further evidence. PPARα plays 
a central role in the regulation of FAO and levels in the skeletal muscle tended to in-
crease in both genotypes on high-fat diet, but WT mice displayed significance in eleva-
tion, whereas KO mice did not (23). MC5R presence in WT mice increased the amount 
of FAO occurring when compared to KO mice. In addition, AMPKa is a fuel detecting 
enzyme that serves as a central point for energy homeostasis, primarily in the stimulation 
of fatty acid oxidation and glucose uptake (1). For WT and KO groups, high-fat diet 
caused AmpKa expression to increase, but only significantly in the KO genotype. The 
deficiency of MC5R may have caused a decrease of FAO in the muscle, and consequent-
ly a lack in energy supply. When fuel is low, AmpKa is activated to attempt to create 
energy by oxidizing fat or taking in excess glucose. It is suggested that the mechanism 
by which AmpKa activation increases glucose uptake is through insulin sensitization in 
the skeletal muscle. The significant increase in AmpKa expression in KO mice between 
low-fat and high-fat diet may indicate that the absence of MC5R increased insulin sensi-
tivity in the skeletal muscle (40). Glycolysis activity in the skeletal muscle was shown 
by the rate-limiting enzyme for glycolysis, PFK-1 (30). On low-fat diet, the deletion of 
MC5R caused drastic stimulation of glycolysis in the skeletal muscle. When high-fat diet 
was administered, the rate of glycolysis increased in the WT genotype, but significantly 
decreased in the KO group, when compared to low-fat groups. MC5R plays an important 
role in regulating glucose oxidation in the skeletal muscle. Akt1 inhibits apoptosis and 
plays a role in insulin sensitivity in skeletal muscle (63). In both WT and KO groups, 
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Akt1 expression was elevated on high-fat diet. While both genotypes exhibited higher 
Akt1 levels on high-fat diet, on each diet, KO mice tended to show lower levels than WT 
mice. The tendency of Akt1 to show lower expression in MC5R KO mice suggests that 
MC5R may have affected the rate of apoptosis in skeletal muscle. Additionally, the in-
crease of Akt1 in response to high-fat diet administration demonstrated a positive corre-
lation between high-fat diet and cell growth. Overall, FAO in skeletal muscle was signif-
icantly affected by the combination of the deletion of MC5R and high-fat consumption. 
The lack of MC5R reduced FAO in skeletal muscle when excess fat was present. Simi-
larly, glycolysis is affected by MC5R. Under normal diet circumstances, MC5R absence 
caused an elevation in the rate of glycolysis. When a high-fat diet was given to the KO 
mice, glycolysis drastically decreased. Again, the existence of surplus dietary fat altered 
the effect of MC5R in skeletal muscle. Interestingly and in contrast to glycolysis, insulin 
sensitivity increased in KO mice on high-fat diet. The increase in insulin sensitivity in 
KO high-fat diet skeletal muscle could be partially responsible for the outcome seen in 
the ITT analysis.  
 
The liver is a central site for FAO in the body (32). FGF-21 is a metabolic protein which 
can regulate the rate of fatty acid oxidation and/or be responsible for insulin activity (12, 
71). Levels of FGF-21 in the low-fat diet mice were not significantly different, although 
the KO group trended towards lower levels when compared to the WT group. However, 
when placed on high-fat diet, FGF-21 expression slightly increased in the WT genotype, 
but drastically increased in the KO genotype. The data suggests that, as opposed to the 
 83 
WT mice, the deletion of MC5R in the KO mice causes a either a significant increase in 
fatty acid oxidation or an increase in insulin sensitivity controlled by FGF-21 when the 
animal is on high-fat diet.  In contrast, FAO stimulated by PPARα in the liver is oppo-
sitely affected by MC5R when compared to FGF-21 (32). High-fat diet feeding de-
creased FAO in both genotypes, but only KO mice experienced a significant decrease in 
PPARα expression. Between high-fat diet groups, KO mice had significantly lower 
PPARα levels than WT mice. This data suggests that PPARα might regulate the oxida-
tion of fatty acids, FGF-21 is involved in insulin sensitivity, and MC5R plays a major 
role in regulating both metabolic pathways in the liver. Although there is a difference in 
FAO between groups, as seen by PPARα expression, MC5R expression did not signifi-
cantly affect MCAD expression in the liver. Similar to PPARα, there was a decreasing 
trend in MCAD expression from low-fat diet groups to high-fat diet groups, as well as a 
decrease from WT mice to KO mice in both diet groups. The data suggests a decrease in 
FAO of transported medium chain fatty acids in mice on high-fat diet, as well as in KO 
mice. MC5R deletion might have decreased FAO of transported fats in the liver, but 
there were no significant differences. Contrasting to its relative MCAD, LCAD, which is 
a marker for long chain fatty acid oxidation, may be regulated further by fat intake, ra-
ther than MC5R.  High-fat diet fed mice exhibited lower LCAD levels, but only WT 
mice showed a significant decrease from low-fat to high-fat.  HSL is another gene which 
is involved in lipid metabolism, specifically in the breakdown of lipids in preparation for 
oxidation, storage, etc. (18). While a high-fat diet tended to decrease HSL mRNA levels 
in both genotypes, WT mice had a significant decrease while KO mice did not. Similarly 
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to the expressions of genes involved in fat breakdown, high-fat diet decreased adipose 
breakdown in the liver. Since the livers of the WT mice were burning fat at a higher rate 
than KO mice, a gene involved in fat storage, DGAT2, was investigated to further ex-
plain the lipid metabolism in the liver.  Diacylglycerol O- acyltransferase 2, or DGAT2, 
is involved in lipid storage in the tissue (42). While low-fat diet did not affect DGAT2 
mRNA levels in the liver of either genotype, high-fat diet feeding altered expression, but 
in contrasting directions. Excessive fat intact caused the WT mice to experience a de-
crease in DGAT2 levels, while the KO mice had a significant increase in DGAT2 levels. 
The data suggests that MC5R might reduce lipid storage in the liver. While the presence 
of MC5R and an elevation in fat intake caused a decrease in fat storage in the liver, the 
deletion of MC5R under similar circumstances caused adipose to accumulate in the liver, 
as opposed to being oxidized. The excess storage of lipids in the liver may be induced by 
the reduction of FAO in KO mice skeletal muscle and liver.   
 
Glucose oxidation, or glycolysis, in the liver was measured by the expression of PFK-1 
(30). For both diets, MC5R KO mice trended towards lower PFK-1 levels than WT 
mice. Dietary differences were not evident between genotypes. The absence of MC5R 
caused a decrease in the rate of glycolysis, independent of diet. Insulin sensitivity and 
lipid metabolism in the liver is also regulated, in part, by Akt1. Akt1 stimulates insulin 
sensitivity in liver cells and is a regulator of glucose homeostasis (61). Additionally, 
Akt1 expression may decrease fatty acid oxidation. It has been suggested that Akt1 plays 
a role in regulating lipid metabolism in skeletal muscle (3). Evidence suggests that Akt1 
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expression creates a tonic decrease in FAO in skeletal muscle (3). Akt1 and lipid meta-
bolism in the liver has not been extensively investigated or reported, but studies in simi-
lar tissues, such as skeletal muscle, have suggested an association. Compared to WT 
mice, KO mice had a tendency to be lower on low-fat diet, but were significantly higher 
on high-fat diet. Additionally, KO mice had a 500% increase in Akt1 levels on high-fat 
diet as opposed to low-fat diet. This suggests that MC5R deletion may have increased 
insulin sensitivity and/or decreased FAO in the liver of KO obese mice. As seen by all 
genes analyzed representing lipid metabolism, the absence of MC5R caused a decrease 
in FAO in the liver, independent of diet. Instead of being oxidized, the surplus lipids in 
the liver accumulated and was stored as adipose. While there was a decrease in FAO in 
the liver of KO mice, MC5R stimulated an increase in the rate of glycolysis. Not only 
might the KO mice have had a hindered ability to metabolize fat and instead stored ex-
cessive fat, their ability to metabolize glucose was disabled as well. Further, in response 
to high-fat diet, the lack of MC5R might have increased insulin sensitivity, seen by Akt1 
and FGF-21 levels. While both genes expressed similar levels in WT and KO mice on 
low-fat diet, expression is significantly increased in KO mice when fed high-fat diet. The 
elevation in dietary fat caused the KO mice to increase their insulin sensitivity. 
 
Omental adipose tissue is a region of fat that has the potential to negatively affect one’s 
overall health. The omentum is relatively close in proximity to the liver, and excess of 
fat tissue in this region can cause health risks such as high LDL cholesterol, high blood 
pressure, and high blood sugar, and cardiometabolic diseases (34).  FAO can be a consi-
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derable aid in reducing the size of the omentum. MCAD, which again measures fatty 
acids transported into the tissue and oxidized, was not significantly affected by MC5R. 
On low-fat diet and high-fat diet, MC5R KO mice tended to exhibit slightly lower levels 
of MCAD expression than WT mice. While on high-fat diet, average fatty acid oxidation 
was elevated in both genotypes. The data shows that dietary fat intake and/or MC5R 
may have played a small role in regulating fatty acid oxidation of transported fatty acids 
by stimulating MCAD in adipose tissue. Similarly, LCAD expression may be affected 
by both dietary fat intake and MC5R. While LCAD expression represents the oxidation 
of fatty acids which are stored in the tissue, the results were parallel to MCAD expres-
sion in omental fat. Dietary fat intake and MC5R may regulate FAO by stimulating 
LCAD in adipose tissue (48). Like FAO, the rate of glycolysis can be altered due to var-
ious stimulants or antagonists. In omental fat, Akt1 acts as an activator of glycolysis 
(31). Even though high-fat diet tended to increase average Akt1 levels, WT at a higher 
rate than KO, expression, and therefore glycolysis, in adipose tissue was not significant-
ly affected by MC5R or dietary fat intake.  Omental fat is involved in lipid metabolism 
and in insulin sensitivity. PPARγ has various duties and its expression is one way to not 
only understand omental fat’s role adipogenesis, but in insulin sensitivity as well. When 
given a low-fat diet or a high-fat diet, MC5R KO mice expressed a lower average of 
PPARγ than WT mice. Additionally, while WT mice had consistent levels on each diet, 
a high-fat diet caused KO mice to increase PPARγ levels. MC5R and dietary fat intake 
can alter PPARγ, which, when activated in adipose, serves as a stimulant of whole body 
insulin sensitivity and/or stimulates adipogenesis (52). Another gene which is involved 
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in insulin activity, SREBP1c, was also affected by both MC5R existence and dietary fat. 
SREBP1c in omental adipose tissue is stimulated by insulin and serves as the primary 
transcription factor for lipogenesis in adipose tissue (14, 38, 49, 52). The deletion of 
MC5R did not affect SREBP1c under normal circumstances, but the consumption of a 
high-fat diet caused SREBP1c levels to significantly increase from the KO low-fat diet 
group and non-significantly increase when compared to the WT high-fat group. While 
the volume of omental fat, as shown by the lipogenic effect of SREBP1c, increased in 
the absence of MC5R, insulin sensitivity elevated as well. In omental fat, FAO was 
somewhat altered by the presence of MC5R.  On both diets, KO mice experienced insig-
nificantly lower expressions of genes related to FAO. Comparable to skeletal muscle, the 
lack of MC5R caused a reduction in FAO. Additionally, MC5R is significantly involved 
in insulin sensitivity in the omental fat. As seen by PPARγ and SREBP1c expression, 
insulin sensitivity increased in KO on high-fat diet, but not in WT mice. Concerning 
overall FAO in omental fat, no values were significant, but there were trends that the ab-
sence of MC5R may lower FAO in KO mice. PPARγ expression alternately suggests 
that adipogenesis was increased in KO mice when fed a high-fat diet. This suggests that 
omental fat did not play a large role in FAO in the body. On the other hand, insulin sen-
sitivity appeared to be affected by omental fat. WT mice experienced no affect by dieta-
ry fat on insulin activity, but KO mice showed a significant contrast between diets. In-
stead of having an increase in insulin resistance when their fat intake increased, MC5R 
mice showed an increase in insulin sensitivity. The increase suggests dissociation be-
tween fat intake and insulin resistance in the omental fat.  
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BAT is a tissue which is involved in FAO and thermoregulation (53, 73). MC5R is 
present in this tissue and has an effect on regulating BAT metabolic functions.  For ex-
ample, when measuring FAO by the expression of MCAD, we found that MC5R played 
a large role in regulating MCAD, or the oxidation of medium chain fatty acids, in BAT. 
When fed a low-fat diet KO mice burned a significantly higher amount of fatty acids 
than WT mice. On high-fat diet both genotypes expressed similar rates of FAO; WT 
mice experienced a significant increase in FAO when compared to low-fat diet while KO 
mice maintained their elevated expression. In contrast to MCAD expression, LCAD ex-
pression was not altered significantly between treatment groups. LCAD expression on 
low-fat diet was similar to MCAD expression in that MC5R KO mice had a higher level 
of oxidation of stored fatty acids than WT mice. When placed on high-fat diet, WT mice 
had no differing effects, while KO mice experienced a decline in LCAD expression, and 
therefore long chain, or stored fatty acid oxidation (73). These trends suggest that MC5R 
affected the regulation of FAO of stored fatty acids on both diets. Under low-fat diet 
feeding in KO mice, FAO increases in BAT, but when excess fat is presented into the 
body, FAO does not increase further but is maintained.  FGF-21 is a key regulator of 
FAO in BAT (12). The data shows that on either diet, MC5R deficiency did not have an 
influence on FAO in BAT. While both genotypes experienced an increase in FGF-21 
expression on high-fat diet, only WT mice displayed a significantly higher increase. Ad-
ditionally, MC5R may play a role in regulating the enzyme SREBP1c, which is involved 
in adipocyte differentiation and lipogenesis (14, 50, 62). SREBP1c expression was not 
significantly altered between treatment groups, but there was a contrast in expression 
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between low-fat diet genotypes. The deletion of MC5R caused an increase in adipogene-
sis under low-fat diet circumstances. When administered a high-fat diet, MC5R KO 
mice’s rate of adipogenesis declined to rival those of WT mice on either diet. This sug-
gests that the lack of MC5R affected the rate of lipogenesis in BAT, but only on low-fat 
diet. PPARγ’s presence in BAT caused alterations in the tissue’s metabolism of adipo-
cytes and insulin activity (53). In the area of lipid metabolism, the activation of PPARγ 
in BAT has been shown to stimulate adipocyte differentiation. PPARγ’s role in insulin 
sensitivity is not clear seeing as some studies indicate that PPARγ stimulation causes 
insulin sensitivity in the body while others suggest PPARγ stimulation leads to insulin 
resistance (54). In this study, PPARγ expression was significantly decreased in both ge-
notypes on high-fat diet. While on low-fat diet, KO mice tended to have a higher average 
of PPARγ expression when compared to WT mice, but there was no significant differ-
ence. This data suggests that high-fat diet intake may alter the activity of PPARγ and 
therefore, adipogenesis in BAT. The effect of MC5R on insulin activity through PPARγ 
is unclear. Akt1 is active in regulating insulin motivated glucose uptake in BAT (65). 
While there were no substantial changes in Akt1 expression between groups, there were 
trends between low-fat and high-fat diets. Both genotypes displayed a decline in Akt1 
expression when placed on high-fat diet. While the presence of MC5R may not play a 
role in regulating Akt1, dietary fat intake may have an effect on the regulation of the 
gene and decrease insulin regulation of glucose uptake in BAT. Data proposes that 
MC5R did play a significant role in FAO in BAT. The deletion of MC5R caused an in-
crease in FAO under low-fat diet circumstances. When given high-fat diet, KO mice 
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maintained elevated FAO, while WT mice experienced a significant elevation in re-
sponse to the excess dietary fat. Additionally, adipogenesis was altered similarly to 
FAO, as seen by Akt1 expression levels. BAT may have experienced an elevation of 
FAO in response to the decrease of FAO in skeletal muscle. Furthermore, insulin sensi-
tivity was affected by MC5R. While insulin sensitivity decreased in BAT as expected in 
both genotypes when fed high-fat diet, sensitivity was maintained in KO mice fed a low-
fat diet. This suggests that under basal circumstances, the absence of MC5R caused the 
animal to be more insulin sensitive.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 91 
CHAPTER IV 
 
SUMMARY AND CONCLUSIONS 
SUMMARY 
 
The results of this project suggest that MC5R plays a role in lipid metabolism and insu-
lin sensitivity. Body weight and food intake data shows that MC5R KO mice might have 
the ability to gain more weight than WT mice do when fed a high-fat diet over a period 
longer than 9 weeks. ITT analysis showed that the absence of MC5R may cause obese 
mice not only to maintain their insulin sensitivity, having glucose absorbance values ri-
valing those of WT and KO on low-fat diet, but begin to experience an increase in insu-
lin sensitivity greater than the low-fat diet mice. In this study, MC5R expression serves 
as a means by which obesity and insulin resistance were dissociated.  RT-PCR results 
further support the idea that MC5R had an effect on metabolic activities. In skeletal 
muscle and liver, FAO decreases in KO mice on high-fat diet. To compensate for the 
excess fat accumulated from the reduction of FAO in skeletal muscle, the liver stored 
surplus fat and the BAT exhibited an increase in FAO of medium chain fatty acids, or 
readily available energy. We interpret the body weight gain data to suggest that high-fat 
feeding for a longer period than 9 weeks would cause the liver will continue to store fat 
and cause body weight to increase. Furthermore, glycolysis was only affected by MC5R 
in the skeletal muscle. While low-fat feeding elevated the rate of glycolysis in the skelet-
al muscle of KO mice, high-fat feeding decreased glycolysis in this tissue. Lastly, the 
ITT evidence for increased insulin sensitivity in KO mice on high-fat diet might be attri-
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buted to improved insulin sensitivity in multiple tissues. Specifically, in skeletal muscle, 
liver, and BAT of MC5R KO mice, high-fat feeding increased the expression of molecu-
lar markers of insulin sensitivity. KO mice also displayed an increase in insulin sensitivi-
ty in BAT on low-fat diet. Overall, these data suggest that insulin resistance and obesity 
were no longer associated when MC5R was absent. 
 
Figure 41 displays an overall picture of the effects MC5R has on each specific tissue’s 
metabolic activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41. Summary of MC5R Effects on Tissue’s Metabolic Activity.  
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- Insulin sensitivity in-
creased on HFD 
 
- Adipogenesis in-
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- Increased insulin 
sensitivity on HFD 
- Increased FAO of cir-
culated fatty acids on 
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CONCLUSIONS 
 
The understanding we have gained of the role of MC5R in lipid metabolism and insulin 
sensitivity will potentially aid the understanding of the mechanism by which the two are 
related. This mechanism pertaining to MC5R’s involvement in the dissociation of exces-
sive weight gain and insulin resistance could be used in the future to develop therapeutic 
drugs that could prevent the onset of early type 2 diabetes in a person who is becoming 
overweight and/or obese. The fear of becoming diabetic as a result of developing obesity 
would be lessened. The two no longer would necessarily go hand in hand. 
 
Further studies that should be conducted include: 
- Feeding a high-fat diet to MC5R KO mice for 12 weeks or longer. 
- Further RT-PCR and western blotting of various metabolic genes involved in li-
pid metabolism and insulin activity in tissues of MC5R KO mice on low-fat and 
high-fat diets. 
- Investigation of tissues such as heart, kidneys, and brain of MC5R KO mice fed a 
high-fat diet. 
- Behavioral evaluation of mice to investigate depression related behavior of 
MC5R KO mice.  
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APPENDIX A 
EXPERIMENTAL PROTOCOLS 
INSULIN TOLERANCE TESTING (ITT) 
(Dr. Chaodong Wu) 
 
Supplies: 
 
Gloves of various sizes 
Sharpie 
Allergy-free syringe 
Heparin tubes 
20 µl pipette and tips 
Ice bucket 
Welled plate 
Surgical scissors 
Kim wipes 
Insulin  
Glucose reagent 
 
 
Procedure: 
 
1. Organize mice for easy and fast selection 
2. At 0 timepoint, inject mice with insulin (1 U/kg) 
3. Collect blood sample (5 µl) from tail vein at 15, 30, 45, and 60 min after bolus 
insulin injection 
4. Place samples in heparin tube, then on ice 
5. Centrifuge samples and extract plasma 
6. Place plasma sample in well with glucose reagent, alongside glucose standards 
7. Measure absorbency over timepoints 
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KILL DAY SET-UP & CHECKLIST 
 
General 
 Tape bench papers on lab benches and line with extra bench papers; 
replace bench papers as necessary. 
 Place gloves, boxes of Kim wipes, sufficient napkins, utensils, and sharpies at 
kill station. 
 Tape 2 biohazard bags on benches near kill station 
 Make RNAse-free & regular 1X PBS solution, ensure plenty and chill in 4° C. 
 Complete rat’s 48-hr diet intakes 
 Place foil packets at kill station for tissue collection 
 
Kill Station 
 Ziploc bags for rat bodies 
 PBS in glass -RNAse Free 
 Surgical tools 
 Straight scissors (black handle) 
 Forceps 
 Extra bench papers 
 2 ml tubes for plasma collection 
 Ice bucket for plasma 
 EDTA for plasma collection 
 200 ul pipette with tips 
 Liquid Nitrogen Container 
 Balance 
 Sharpie 
 Gloves 
 
Blood Station 
 Centrifuge 
 2 ml tubes for plasma collection 
 Funnel 
 Ice bucket for plasma 
 EDTA for plasma collection 
 200 ul pipette with tips 
 
 
Morning of Kill 
 
1. 2. Scoop lots of ice and fill necessary containers 
2. Make 1X PBS solution and chill 
3. Remove denaturation solution from fridge; keep in ice. 
4. Turn on centrifuge  
5. 7. Prepare and move mice from basement to kill station; keep food in cages 
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6. Pre-weigh foil packets and make sure they are labeled properly and placed at kill 
station 
 
After Kill 
 
1. Store samples in appropriate place 
2. Clean up 
3. Autoclave biohazard trash and bring to dumpster 
4. Bring mice bodies to freezer in basement  
5. Wash tools and glassware; put to dry in oven 
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RNA EXTRACTION PROTOCOL 
(Dr. Caurnel Morgan) 
 
 
Supplies: 
 
2 ml tubes 
Glass mortar and pestle and/or 18-gauge needle 
50 ml conical 
Centrifuge 
Vortex 
Water bath 
Homogenization buffer 
Beta-Mercaptoethanol 
1X Protein digestion Buffer 
Proteinase K 
100% Ethanol 
Phenol Chloroform 
Acidic Phenol Chloroform 
5 M NaCl 
Water 
Ice Bucket 
 
 
Procedure: 
 
1. Prepare tissue homogenate: 
a. You will need 3mL of homogenization buffer for each sample, plus 
2mL extra buffer (E.g., 6 samples requires 20mL buffer). 
b. Add 7uL beta-mercaptoethanol (BME) to homogenization buffer to 
get 0.1M BME. (For 6 samples, 20mL homogenization buffer, this 
would require 140uL BME)  
c. Add 30mg-150mg tissue to 3mL homogenization buffer. Homogenize 
the tissue using a glass mortar and pestle and/or passing the tissue 
through an 18-gauge needle. 
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2. Precipitate RNA: 
a. Add at least 3 volumes of 4M lithium chloride to the homogenate (for 
a 3mL homogenate, this would require at least 9mL 4M LiCl). Mix by 
inverting until there are no separate layers of liquid. 
b.  Precipitate the RNA at 4^C overnight. 
c. Sediment the RNA at 10,000g at 4^C for 1.5 hours.  
d. Decant the supernatant. 
 
3. Protein Removal: 
 
a. Prepare a 45^C water bath. Add proteinase K to 0.2mg/mL in 1X pro-
tein digestion buffer. You will need 0.5mL buffer per sample. 
b. Decant the supernatant off the RNA-containing pellet. Save the su-
pernatant for protein and/or DNA extraction. 
c. Re-suspend the pellet in 0.5mL protein digestion buffer with protei-
nase K. The pellet will be hard at first. Incubate the pellet at 45^C for 
2-5 minutes and break up the pellet by vortexing and/or using an 18-
gauge needle. 
d. Incubate the sample in protein digestion buffer for 1 hour at 45^C. 
e. Adjust volume to 0.8-1.0mL with water. Phenol/chloroform extract 
the sample until the interphase is completely clear. Always do at least 
2 extractions. 
f. Add 2-2.5 volumes ethanol to the sample and mix by inverting several 
times.  Alternatively, you may add 0.6-1.0 volumes of isopropanol in-
stead of ethanol. Add 1/24th volume 5M NaCl to the sample and mix 
by briefly vortexing. Store the RNA on ice for at least 15 minutes. 
g. Sediment the RNA by spinning at 15,000g for 15 minutes at 4^C. De-
cant off the supernatant and remove the residual supernatant with a 
pipette. 
h. Re-suspend the pellet in 400uL water. Extract twice with acidic phe-
nol. 
i. Repeat steps 8 and 9. 
j. Add 0.3mL-1.0mL 70% ethanol the each sample and loosen the pellet 
by vortexing. 
k. Sediment the RNA at 12,000g for 5 minutes at 4^C. Decant off the 
supernatant and remove the residual ethanol by pipette. 
l. Re-suspend the pellet in water or formamide. 
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Notes:  
1. For RNAse-rich tissues you should homogenize 20-30mg of tissue. You 
may want to pre-grind the tissue in liquid nitrogen. 
 
a. Very tough tissues such as muscle or heart can either be frozen 
and crushed in liquid nitrogen beforehand or (quickly!) cut into 
smaller pieces with scalpels while submerged in homogenization 
buffer. 
b. If extracting from fat tissue, place on ice, directly after homoge-
nizing, for 5 minutes. Centrifuge and extract out the middle 
aqueous layer which contains the RNA. 
 
 
Solutions:   
 
Homogenization Buffer 
Mix in a 50mL tube: (final concentrations in parentheses) 
26.7mL GuanidiniumThiocyante, 6M (4M) 
2.0mL Tris, pH 7.5, 1M (50mM) 
2.0mL EDTA, 0.2M (10mM) 
1.0mL 20% Sodium N-Lauroyl Sarcosine (0.05%) 
Adjust final volume to 40mL with ddH2O 
 
 
10X Protein Digestion Buffer 
Mix in a 50mL tube: (final concentrations in parentheses) 
4.0mL Tris, pH 7.9, 1M (100mM) 
10.0mL EDTA, 0.2M (50mM) 
20.0mL 20% Sodium N-Lauroyl Sarcosine (10%) 
Adjust final volume to 40mL with ddH2O 
 
 
 
Acidic Phenol-Chloroform: 
 
Component By Number of Sam-
ples 
For 6 Samples 
Buffered Phenol organic 
phase pH 4.5 
0.83mL * Sample # 4.98mL (5mL) 
Chloroform 0.17mL * Sample # 1.02mL (1mL) 
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MMLV REVERSE TRANSCRIPTASE PROTOCOL 
 
 
Supplies:  
 
Thermocycler 
0.65 ml tubes 
20 μl pipette with tips 
200 μl pipette with tips 
Heat block 
dNTPs 
Random hexamers 
10X M-MLV Buffer 
M-MLV 
RNAse inhibitor  
Water 
 
 
Procedure: 
 
1. Thermal Cycler and Heat Block Preparation 
a. Set the heat block to 65^C. 
b. Program the thermal cycler: set the heated lid to 70^C. Pro-
gram the cycler to hold at 25^C until released, 25^C for 10 
min, 37^C for 50 min and 70^C for 15 min.  
c. Allow sufficient time for the block and thermal cycler to reach 
start temperatures. 
 
2. Master Mix A preparation 
a. Calculate the amount of master mix according to the “master 
mix A” table and add the appropriate amount of each compo-
nent. 
b. Mix master mix A by pipetting. 
 
 
 
 
 113 
 
Component Calculation 
dNTPs (10mM each) 1.1uL * sample num-
ber 
50ng/uL random hexamers 1.1uL * sample num-
ber 
 
 
3. Sample Preparation 
a. Dilute 1500ng of each RNA to a final volume of 10uL in a 
0.5mL microcentrifuge tube. 
b. Add 2uL Master Mix A to each sample 
c. Incubate samples at 65^C for 5-10min 
d. Transfer samples immediately to ice. After at least 2 min, 
quick spin the samples and place them back on ice. 
 
4. Master Mix B preparation 
a. Calculate the final volume of master mix B by multiplying 
(number of samples + 0.5) * 8uL. 
b. Thaw the 10X M-MLV buffer and invert the tube until all the 
white precipitate dissolves. Add the appropriate amount of 
each component to the master mix (see table below). 
c. Mix by pipetting 
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5. RT Reaction 
a. Add 8uL master mix B to each sample and mix by pipetting. 
b. Put samples into the thermal cycler and release the hold. 
 
Component Calculation 
10X M-MLV 
Buffer 
2 * (sample # +0.5) 
M-MLV 1.2 * (sample # +0.5) 
RNAse Inhi-
bitor 
1uL 
Water To final volume 
Final Volume 8* (sample # +0.5) 
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RT-PCR PROTOCOL 
 
Supplies:  
 
Thermocycler 
0.65 ml tubes 
20 μl pipette with tips 
200 μl pipette with tips 
 2X Ready Mix 
 RNA from sample tissue 
 Primer mix 
Water 
 
 
Procedure: 
 
1. Prepare the thermal cycler 
a. Calculate the extension time by multiplying amplicon length in kb * 
60s (minimum 30s).  
b. Determine the hybridization temperature by the lower Tm (in 50mM 
NaCl) of the two primers. 
c. Determine cycle number based on the abundance of the mRNA. 
d. Program the thermal cycler: Set the heated lid to 101^C. Program the 
machine to hold at 94^C until released, 94^C for 50s, Repeat [cycle 
number] of times: (94^C 20s, [hybridization temperature] 20s, 72^C 
for [extension time]), 4^C hold. 
 
 
 
 
 
 
 
 116 
2. Master Mix preparation 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Sample Preparation 
a. For each sample, add 2uL cDNA + 14uL master mix to a tube on ice. 
b. Start thermal cycler. When the lid and the sample block have both 
reach temperature, add the samples to the block. 
c. Close the lid and release the 94^C hold. 
 
  
Component Calculation 
2X Ready Mix 8uL * (sample number + 0.5) 
Primer Mix (10uM each) 0.8uL * (sample number + 
0.5) 
Water 5.2uL * (sample number + 
0.5) 
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